{
  "meta": {
    "id": "test13",
    "title": "Gynae Oncology",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "Which of the following statements regarding squamocolumnar junction is false?",
      "options": [
        {
          "label": "A",
          "text": "The squamocolumnar junction everts outside with age under the influence of estrogen.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Endocervix is lined with squamous epithelium and ectocervix is lined with columnar epithelium.",
          "correct": true
        },
        {
          "label": "C",
          "text": "Endocervix undergoes Squamous metaplasia.",
          "correct": false
        },
        {
          "label": "D",
          "text": "Metaplastic cells in this transformation zone are prone to develop Cervical cancer.",
          "correct": false
        }
      ],
      "correct_answer": "B. Endocervix is lined with squamous epithelium and ectocervix is lined with columnar epithelium.",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/17/whatsapp-image-2023-06-12-at-1901127.jpg"
      ],
      "explanation": "<p><strong>Ans. B. Endocervix is lined with squamous epithelium and ectocervix is lined with columnar epithelium.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Squamocolumnar junction is the transition zone between the endocervix and ectocervix.</li><li>\u2022 Endocervix is lined with columnar epithelium which gets abruptly transformed into Ectocervix which is lined with squamous epithelium. This is known as Squamous metaplasia.</li><li>\u2022 With age, under the influence of estrogen, the endocervix everts out and the transformation zone keeps coming outwards the internal os. This zone is prone to HPV infection resulting in development of carcinoma cervix.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e4675a17",
      "audio": ""
    },
    {
      "text": "The most preventable gynecological cancer is:",
      "options": [
        {
          "label": "A",
          "text": "Breast cancer",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cervical cancer",
          "correct": true
        },
        {
          "label": "C",
          "text": "Endometrial cancer",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ovarian cancer",
          "correct": false
        }
      ],
      "correct_answer": "B. Cervical cancer",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Cervical cancer</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c7957d1b",
      "audio": ""
    },
    {
      "text": "The most preventable gynaecological cancer is :",
      "options": [
        {
          "label": "A",
          "text": "Breast cancer",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cervical cancer",
          "correct": true
        },
        {
          "label": "C",
          "text": "Endometrial cancer",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ovarian cancer",
          "correct": false
        }
      ],
      "correct_answer": "B. Cervical cancer",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Cervical cancer</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f9e199ef",
      "audio": ""
    },
    {
      "text": "Which of the following is NOT true in \u201cWHO global strategy for eliminating cervical cancer\u201d by 2030.",
      "options": [
        {
          "label": "A",
          "text": "70% of girls fully vaccinated by the age of 15 years",
          "correct": true
        },
        {
          "label": "B",
          "text": "70% of women screened by the age of 35 years and again by 45 years",
          "correct": false
        },
        {
          "label": "C",
          "text": "90% of girls fully vaccinated by the age of 15 years",
          "correct": false
        },
        {
          "label": "D",
          "text": "90% of women with precancer/ cancer treated and managed appropriately",
          "correct": false
        }
      ],
      "correct_answer": "A. 70% of girls fully vaccinated by the age of 15 years",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2149e8a6",
      "audio": ""
    },
    {
      "text": "A P4L4, 43-year-old woman presents to OPD with post coital bleeding. On cervical biopsy, she is found to have CIN III. You counsel her about her treatment and also guide her for preventive strategy for her 2 daughters (17 years, 12-year-old) with HPV vaccine. Which of the following is the indigenous cervical cancer vaccine soon to be available in India by serum institute of India:",
      "options": [
        {
          "label": "A",
          "text": "Cervarix",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cervavac",
          "correct": true
        },
        {
          "label": "C",
          "text": "Gardasil",
          "correct": false
        },
        {
          "label": "D",
          "text": "Gardasil 9",
          "correct": false
        }
      ],
      "correct_answer": "B. Cervavac",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Cervavac</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0d78ee78",
      "audio": ""
    },
    {
      "text": "Identify the procedure done with the instrument given:",
      "options": [
        {
          "label": "A",
          "text": "Ayers spatula for Pap smear",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cytobrush for Liquid based cytology",
          "correct": true
        },
        {
          "label": "C",
          "text": "Pipelle\u2019s for endometrial aspiration",
          "correct": false
        },
        {
          "label": "D",
          "text": "Vaginal swab for chlamydia screening",
          "correct": false
        }
      ],
      "correct_answer": "B. Cytobrush for Liquid based cytology",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/17/whatsapp-image-2023-06-12-at-190188_nDAGw7I.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "63fbe8c6",
      "audio": ""
    },
    {
      "text": "Identify the procedure being done in the image given below?",
      "options": [
        {
          "label": "A",
          "text": "Cervical biopsy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Endometrial aspiration",
          "correct": false
        },
        {
          "label": "C",
          "text": "HPV testing",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pap\u2019s smear",
          "correct": true
        }
      ],
      "correct_answer": "D. Pap\u2019s smear",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/16/2_NDv9EG0.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Pap\u2019s smear</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a8fb5963",
      "audio": ""
    },
    {
      "text": "Mrs X, 45-year-old female comes for cervical cancer screening. Identify the procedure being done in the image:",
      "options": [
        {
          "label": "A",
          "text": "Colposcopy",
          "correct": false
        },
        {
          "label": "B",
          "text": "High vaginal swab",
          "correct": false
        },
        {
          "label": "C",
          "text": "Liquid based Cytology",
          "correct": true
        },
        {
          "label": "D",
          "text": "Pap\u2019s smear",
          "correct": false
        }
      ],
      "correct_answer": "C. Liquid based Cytology",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/17/whatsapp-image-2023-06-12-at-190189.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e4a2fc34",
      "audio": ""
    },
    {
      "text": "A 38-year-old female, P3L3 comes to Gynaecology OPD for routine checkup, and you offer her cervical cancer screening. Which is the preferred primary modality for cervical cancer screening",
      "options": [
        {
          "label": "A",
          "text": "Colposcopy",
          "correct": false
        },
        {
          "label": "B",
          "text": "HPV testing",
          "correct": true
        },
        {
          "label": "C",
          "text": "Liquid based Cytology",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pap\u2019s smear",
          "correct": false
        }
      ],
      "correct_answer": "B. HPV testing",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/16/5_0BGImRb.jpg"
      ],
      "explanation": "<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d101bc6a",
      "audio": ""
    },
    {
      "text": "Human Papilloma Virus (HPV) is the causative agent in majority of cervical cancers. Which of the following is TRUE in relation to HPV testing as per WHO guidelines?",
      "options": [
        {
          "label": "A",
          "text": "HPV testing should be used as a method of cancer cervix screening after 25 years of age",
          "correct": false
        },
        {
          "label": "B",
          "text": "HPV should only be used in adjunct with either Pap\u2019s smear or liquid based cytology",
          "correct": false
        },
        {
          "label": "C",
          "text": "An interval of 5-10 years is recommended when using HPV as primary screening",
          "correct": true
        },
        {
          "label": "D",
          "text": "Women with previous 2 HPV screen negative can stop screening after the age of 60 years",
          "correct": false
        }
      ],
      "correct_answer": "C. An interval of 5-10 years is recommended when using HPV as primary screening",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 WHO recommends starting regular cervical cancer screening at the age of 30 years among the general population of women. WHO recommends using HPV DNA detection as the primary screening test rather than VIA or cytology in screening and treatment approaches among both the general population of women and women living with HIV WHO suggests a regular screening interval of every 5 to 10 years when using HPV DNA detection as the primary screening test among the general population of women After the age of 50 years , WHO suggests screening is stopped after two consecutive negative screening results consistent with the recommended regular screening intervals among both the general population of women and women living with HIV</li><li>\u2022 WHO recommends starting regular cervical cancer screening at the age of 30 years among the general population of women.</li><li>\u2022 age of 30 years</li><li>\u2022 WHO recommends using HPV DNA detection as the primary screening test rather than VIA or cytology in screening and treatment approaches among both the general population of women and women living with HIV</li><li>\u2022 HPV DNA detection as the primary screening test</li><li>\u2022 WHO suggests a regular screening interval of every 5 to 10 years when using HPV DNA detection as the primary screening test among the general population of women</li><li>\u2022 regular screening interval of every 5 to 10 years when using HPV DNA</li><li>\u2022 After the age of 50 years , WHO suggests screening is stopped after two consecutive negative screening results consistent with the recommended regular screening intervals among both the general population of women and women living with HIV</li><li>\u2022 After the age of 50 years</li><li>\u2022 Other options:</li><li>\u2022 Other options:</li><li>\u2022 Option A: HPV testing should be used as a method of cancer cervix screening after 25 years of age: This is incorrect as screening with HPV should start at age 30 Option B: HPV should only be used in adjunct with either Pap\u2019s smear or liquid based cytology: This is also incorrect. As per WHO, HPV alone is the preferred screening test Option D: Women with previous 2 HPV screen negative can stop screening after the age of 60 years: This is also incorrect. After the age of 50 years , WHO suggests screening is stopped after two consecutive negative screening results consistent with the recommended regular screening intervals among both the general population of women and women living with HIV</li><li>\u2022 Option A: HPV testing should be used as a method of cancer cervix screening after 25 years of age: This is incorrect as screening with HPV should start at age 30</li><li>\u2022 Option B: HPV should only be used in adjunct with either Pap\u2019s smear or liquid based cytology: This is also incorrect. As per WHO, HPV alone is the preferred screening test</li><li>\u2022 Option D: Women with previous 2 HPV screen negative can stop screening after the age of 60 years: This is also incorrect. After the age of 50 years , WHO suggests screening is stopped after two consecutive negative screening results consistent with the recommended regular screening intervals among both the general population of women and women living with HIV</li><li>\u2022 After the age of 50 years</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 WHO recommends starting regular cervical cancer screening at the age of 30 years among the general population of women. WHO recommends using HPV DNA detection as the primary screening test rather than VIA or cytology in screening and treatment approaches among both the general population of women and women living with HIV WHO suggests a regular screening interval of every 5 to 10 years when using HPV DNA detection as the primary screening test among the general population of women After the age of 50 years , WHO suggests screening is stopped after two consecutive negative screening results consistent with the recommended regular screening intervals among both the general population of women and women living with HIV</li><li>\u27a4 WHO recommends starting regular cervical cancer screening at the age of 30 years among the general population of women.</li><li>\u27a4 age of 30 years</li><li>\u27a4 WHO recommends using HPV DNA detection as the primary screening test rather than VIA or cytology in screening and treatment approaches among both the general population of women and women living with HIV</li><li>\u27a4 HPV DNA detection as the primary screening test</li><li>\u27a4 WHO suggests a regular screening interval of every 5 to 10 years when using HPV DNA detection as the primary screening test among the general population of women</li><li>\u27a4 regular screening interval of every 5 to 10 years when using HPV DNA</li><li>\u27a4 After the age of 50 years , WHO suggests screening is stopped after two consecutive negative screening results consistent with the recommended regular screening intervals among both the general population of women and women living with HIV</li><li>\u27a4 After the age of 50 years</li><li>\u27a4 Ref: WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition, 2021</li><li>\u27a4 Ref: WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition, 2021</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ec155753",
      "audio": ""
    },
    {
      "text": "A woman visited hospital in rural area for \u201csee and treat\u201d cervical cancer screening. Which method is being used for screening in the given image:",
      "options": [
        {
          "label": "A",
          "text": "Cervical biopsy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Liquid based cytology",
          "correct": false
        },
        {
          "label": "C",
          "text": "Visual inspection with acetic acid",
          "correct": true
        },
        {
          "label": "D",
          "text": "Visual inspection with lugol\u2019s iodine",
          "correct": false
        }
      ],
      "correct_answer": "C. Visual inspection with acetic acid",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/16/1_akrJ1Ac.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2d196ed2",
      "audio": ""
    },
    {
      "text": "Identify the procedure done in the above image:",
      "options": [
        {
          "label": "A",
          "text": "Cervical biopsy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Liquid based cytology",
          "correct": false
        },
        {
          "label": "C",
          "text": "Visual inspection with acetic acid",
          "correct": false
        },
        {
          "label": "D",
          "text": "Visual inspection with lugol\u2019s iodine",
          "correct": true
        }
      ],
      "correct_answer": "D. Visual inspection with lugol\u2019s iodine",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/16/1_R4PwilP.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9cb5d229",
      "audio": ""
    },
    {
      "text": "A 35-year-old woman underwent Pap smear screening which showed HSIL/ CIN III. The woman was advised further the following test. Identify the procedure:",
      "options": [
        {
          "label": "A",
          "text": "Colposcopy",
          "correct": true
        },
        {
          "label": "B",
          "text": "Hysteroscopy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Laparoscopy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Vaginoscopy",
          "correct": false
        }
      ],
      "correct_answer": "A. Colposcopy",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/16/3_vUJG0SF.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3f07d020",
      "audio": ""
    },
    {
      "text": "A 50-year-old woman is diagnosed to have endometrial carcinoma on biopsy. She wishes to understand the high-risk factors for development of endometrial cancer. Which of the following is NOT a risk factor for development of endometrial carcinoma:",
      "options": [
        {
          "label": "A",
          "text": "Diabetes",
          "correct": false
        },
        {
          "label": "B",
          "text": "Multiparity",
          "correct": true
        },
        {
          "label": "C",
          "text": "Obesity",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tamoxifen therapy",
          "correct": false
        }
      ],
      "correct_answer": "B. Multiparity",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/picture1_orutUsD.jpg"
      ],
      "explanation": "<p><strong>Ans. B. Multiparity</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Risk Factors for endometrial cancer include</li><li>\u27a4 Risk Factors for endometrial cancer include</li><li>\u27a4 Nulliparity Early menarche and late menopause Obesity DM Tamoxifen Atypical Endometrial hyperplasia Unopposed estrogen exposure PCOS Granulosa cell ovarian tumor HRT with only estrogen Genetic syndromes like Lynch syndrome (HNPCC) and Cowden syndrome</li><li>\u27a4 Nulliparity</li><li>\u27a4 Nulliparity</li><li>\u27a4 Early menarche and late menopause</li><li>\u27a4 Early menarche and late menopause</li><li>\u27a4 Obesity</li><li>\u27a4 Obesity</li><li>\u27a4 DM</li><li>\u27a4 DM</li><li>\u27a4 Tamoxifen</li><li>\u27a4 Tamoxifen</li><li>\u27a4 Atypical Endometrial hyperplasia</li><li>\u27a4 Atypical Endometrial hyperplasia</li><li>\u27a4 Unopposed estrogen exposure PCOS Granulosa cell ovarian tumor HRT with only estrogen</li><li>\u27a4 Unopposed estrogen exposure</li><li>\u27a4 PCOS Granulosa cell ovarian tumor HRT with only estrogen</li><li>\u27a4 PCOS</li><li>\u27a4 PCOS</li><li>\u27a4 Granulosa cell ovarian tumor</li><li>\u27a4 Granulosa cell ovarian tumor</li><li>\u27a4 HRT with only estrogen</li><li>\u27a4 HRT with only estrogen</li><li>\u27a4 Genetic syndromes like Lynch syndrome (HNPCC) and Cowden syndrome</li><li>\u27a4 Genetic syndromes like Lynch syndrome (HNPCC) and Cowden syndrome</li><li>\u27a4 Ref: Berek & Novak, 16 ed, page 2362</li><li>\u27a4 Ref: Berek & Novak, 16 ed, page 2362</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "272c7111",
      "audio": ""
    },
    {
      "text": "Identify the instrument given below:",
      "options": [
        {
          "label": "A",
          "text": "Karman canulla",
          "correct": false
        },
        {
          "label": "B",
          "text": "Manual vacuum aspiration cannula",
          "correct": false
        },
        {
          "label": "C",
          "text": "Pipelle endometrial aspiration cannula",
          "correct": true
        },
        {
          "label": "D",
          "text": "Uterine sound",
          "correct": false
        }
      ],
      "correct_answer": "C. Pipelle endometrial aspiration cannula",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/picture2.jpg"
      ],
      "explanation_images": [
        "https://www.mediplusindia.com/wp-content/uploads/2017/10/mi1.jpg",
        "https://5.imimg.com/data5/XU/RN/MY-2413456/mva-syringe.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image-20231217215354-1.png"
      ],
      "explanation": "<p><strong>Ans. C. Pipelle endometrial aspiration cannula</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 An endometrial biopsy can be taken by</li><li>\u27a4 An endometrial biopsy can be taken by</li><li>\u27a4 Hysteroscopy guided endometrial biopsy (Gold standard) Dilatation and curettage Office endometrial aspiration in the OPD</li><li>\u27a4 Hysteroscopy guided endometrial biopsy (Gold standard)</li><li>\u27a4 Hysteroscopy guided endometrial biopsy (Gold standard)</li><li>\u27a4 Dilatation and curettage</li><li>\u27a4 Dilatation and curettage</li><li>\u27a4 Office endometrial aspiration in the OPD</li><li>\u27a4 Office endometrial aspiration in the OPD</li><li>\u27a4 Ref : https://www.semanticscholar.org/paper/Frequency-of-Positive-Endometrial-Pipelle-Biopsies-Zaman-Jabeen/30747f41d85e5bbb4783e846377d979c77102785</li><li>\u27a4 Ref :</li><li>\u27a4 https://www.semanticscholar.org/paper/Frequency-of-Positive-Endometrial-Pipelle-Biopsies-Zaman-Jabeen/30747f41d85e5bbb4783e846377d979c77102785</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a2883e45",
      "audio": ""
    },
    {
      "text": "What procedure is done with the given instrument:",
      "options": [
        {
          "label": "A",
          "text": "Endometrial aspiration cannula for endometrial sampling",
          "correct": true
        },
        {
          "label": "B",
          "text": "Karman cannula for RPOC",
          "correct": false
        },
        {
          "label": "C",
          "text": "Manual Vacuum aspiration for missed abortion",
          "correct": false
        },
        {
          "label": "D",
          "text": "Suction evacuation for molar pregnancy",
          "correct": false
        }
      ],
      "correct_answer": "A. Endometrial aspiration cannula for endometrial sampling",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/picture4.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/picture5.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image-20231217220652-1.jpeg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image-20231217220836-1.jpeg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/picture5.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Endometrial aspiration cannula for endometrial sampling</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 This is an office endometrial aspiration cannula available as many names like pipelle and the vibra aspirator It is used to procure an endometrial aspirate as an OPD procedure as the cannula is so thin, it does not usually require cervical dilatation This procedure is done in women with Abnormal Uterine Bleeding (AUB) The other ways to obtain an endometrial sample for HPE is by Hysteroecopic guided endometrial biopsy (Gold standard) Dilatation and curettage</li><li>\u27a4 This is an office endometrial aspiration cannula available as many names like pipelle and the vibra aspirator</li><li>\u27a4 It is used to procure an endometrial aspirate as an OPD procedure as the cannula is so thin, it does not usually require cervical dilatation</li><li>\u27a4 This procedure is done in women with Abnormal Uterine Bleeding (AUB)</li><li>\u27a4 The other ways to obtain an endometrial sample for HPE is by Hysteroecopic guided endometrial biopsy (Gold standard) Dilatation and curettage</li><li>\u27a4 Hysteroecopic guided endometrial biopsy (Gold standard) Dilatation and curettage</li><li>\u27a4 Hysteroecopic guided endometrial biopsy (Gold standard)</li><li>\u27a4 Dilatation and curettage</li><li>\u27a4 Ref: https://www.semanticscholar.org/paper/Office-endometrial-sampling%3A-a-comparison-between-4-Zutshi-Gupta/25eacdc961e0fae8cb8414abee5961eed481c2f0</li><li>\u27a4 Ref:</li><li>\u27a4 https://www.semanticscholar.org/paper/Office-endometrial-sampling%3A-a-comparison-between-4-Zutshi-Gupta/25eacdc961e0fae8cb8414abee5961eed481c2f0</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6a372aad",
      "audio": ""
    },
    {
      "text": "A 45-year-old woman visits OPD with heavy menstrual bleeding. Her USG is shown below Histopathology shows dilated cystic glands with increased gland: stroma ratio. The probable diagnosis is:",
      "options": [
        {
          "label": "A",
          "text": "Endometrial Carcinoma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Endometrial hyperplasia",
          "correct": true
        },
        {
          "label": "C",
          "text": "Molar pregnancy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Retained product of conception",
          "correct": false
        }
      ],
      "correct_answer": "B. Endometrial hyperplasia",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/picture6.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Endometrial hyperplasia</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Endometrial hyperplasia is a condition where there is endometrial thickening. It can be simple pr complex and with or without atypia. Simple hyperplasia is characterized by dilated or cystic glands with round to slightly irregular shapes, an increased glandular-to-stromal ratio without glandular crowding Complex hyperplasia has architecturally complex (budding and infolding) crowded glands, with less intervering stroma Atypical hyperplasia refers to cytologic atypia and is a high risk for endometrial carcinoma</li><li>\u27a4 Endometrial hyperplasia is a condition where there is endometrial thickening. It can be simple pr complex and with or without atypia.</li><li>\u27a4 Simple hyperplasia is characterized by dilated or cystic glands with round to slightly irregular shapes, an increased glandular-to-stromal ratio without glandular crowding</li><li>\u27a4 Complex hyperplasia has architecturally complex (budding and infolding) crowded glands, with less intervering stroma</li><li>\u27a4 Atypical hyperplasia refers to cytologic atypia and is a high risk for endometrial carcinoma</li><li>\u27a4 Ref: berek & novak, 16 ed, page 2364</li><li>\u27a4 Ref: berek & novak, 16 ed, page 2364</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "36a4812d",
      "audio": ""
    },
    {
      "text": "55-year-old post-menopausal woman presents to OPD with post-menopausal bleeding. Her USG shows endometrial thickness of 7mm. Next step in management is:",
      "options": [
        {
          "label": "A",
          "text": "CA 125",
          "correct": false
        },
        {
          "label": "B",
          "text": "Endometrial aspiration biopsy",
          "correct": true
        },
        {
          "label": "C",
          "text": "Pap smear",
          "correct": false
        },
        {
          "label": "D",
          "text": "Prepare for hysterectomy",
          "correct": false
        }
      ],
      "correct_answer": "B. Endometrial aspiration biopsy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Endometrial aspiration biopsy</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 After physical and pelvic examination, the first test to evaluate for signs of endometrial cancer is transvaginal ultrasound If the endometrial thickness in a post menopausal woman is \u2265 5mm, an endometrial biopsy should be done. An endometrial biopsy can be obtained by Office endomtrial aspiration Dilatation and curettage Hysteroscopy and biopsy (Gold standard)</li><li>\u27a4 After physical and pelvic examination, the first test to evaluate for signs of endometrial cancer is transvaginal ultrasound</li><li>\u27a4 If the endometrial thickness in a post menopausal woman is \u2265 5mm, an endometrial biopsy should be done.</li><li>\u27a4 An endometrial biopsy can be obtained by Office endomtrial aspiration Dilatation and curettage Hysteroscopy and biopsy (Gold standard)</li><li>\u27a4 Office endomtrial aspiration Dilatation and curettage Hysteroscopy and biopsy (Gold standard)</li><li>\u27a4 Office endomtrial aspiration</li><li>\u27a4 Dilatation and curettage</li><li>\u27a4 Hysteroscopy and biopsy (Gold standard)</li><li>\u27a4 Ref: figo cancer report, 2021</li><li>\u27a4 Ref: figo cancer report, 2021</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fe1a1134",
      "audio": ""
    },
    {
      "text": "A 49-year-old woman with biopsy proven endometrial cancer and MRI showing endometrial growth involving more than 50% myometrium is undergoing hysterectomy. What will be your advice regarding removal of ovaries?",
      "options": [
        {
          "label": "A",
          "text": "Ovaries should be conserved",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ovaries should be removed",
          "correct": true
        },
        {
          "label": "C",
          "text": "Ovaries can be removed if they appear pathological",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ovaries should be conserved if patient is pre-menopausal and should be removed if patient is post-menopausal",
          "correct": false
        }
      ],
      "correct_answer": "B. Ovaries should be removed",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Ovaries should be removed</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The recommended surgical procedure in endometrial cancer is an extra-fascial total hysterectomy with bilateral salpingo-oophorectomy.</li><li>\u27a4 The recommended surgical procedure in endometrial cancer is an extra-fascial total hysterectomy with bilateral salpingo-oophorectomy.</li><li>\u27a4 Ref: Figo cancer report 2021</li><li>\u27a4 Ref: Figo cancer report 2021</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7a35d83d",
      "audio": ""
    },
    {
      "text": "A 50-year-old woman underwent hysterectomy with bilateral salpingooophorectomy with pelvic and para-aortic lymphadenectomy for endometrial cancer. Histopathology confirms lymph node involvement. Which of the following statements is correct:",
      "options": [
        {
          "label": "A",
          "text": "The patient has stage IIIb disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "No further treatment required as lymphadenectomy already done",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lymphadenectomy in endometrial cancer helps in staging and guiding further management",
          "correct": true
        },
        {
          "label": "D",
          "text": "The patient will require adjuvant vaginal brachytherappy",
          "correct": false
        }
      ],
      "correct_answer": "C. Lymphadenectomy in endometrial cancer helps in staging and guiding further management",
      "question_images": [],
      "explanation_images": [
        "https://pbs.twimg.com/media/FzFlF3IWAAUU5Rn?format=jpg&name=900x900"
      ],
      "explanation": "<p><strong>Ans. C. Lymphadenectomy in endometrial cancer helps in staging and guiding further management</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Figo cancer report 2021</li><li>\u27a4 Ref: Figo cancer report 2021</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d22d3d7a",
      "audio": ""
    },
    {
      "text": "In relation to endometrial cancer which of the following is CORRECT:",
      "options": [
        {
          "label": "A",
          "text": "Type I endometrial cancer: due to unopposed estrogen",
          "correct": true
        },
        {
          "label": "B",
          "text": "Type I endometrial cancer: due to unopposed progesterone",
          "correct": false
        },
        {
          "label": "C",
          "text": "Type II endometrial cancer: due to unopposed estrogen",
          "correct": false
        },
        {
          "label": "D",
          "text": "Type II endometrial cancer: due to unopposed progesterone",
          "correct": false
        }
      ],
      "correct_answer": "A. Type I endometrial cancer: due to unopposed estrogen",
      "question_images": [],
      "explanation_images": [
        "https://www.researchgate.net/publication/268335090/figure/tbl2/AS:686347681542145@1540649447437/Different-characteristics-of-type-1-and-type-2-endometrial-cancer.png",
        "https://www.researchgate.net/publication/268335090/figure/tbl2/AS:686347681542145@1540649447437/Different-characteristics-of-type-1-and-type-2-endometrial-cancer.png"
      ],
      "explanation": "<p><strong>Ans. A. Type I endometrial cancer: due to unopposed estrogen</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Berek & novak, 16 edition, page 2362</li><li>\u27a4 Ref: Berek & novak, 16 edition, page 2362</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "296cef18",
      "audio": ""
    },
    {
      "text": "Which of the following type of endometrial cancer type has worst prognosis?",
      "options": [
        {
          "label": "A",
          "text": "Endometroid",
          "correct": false
        },
        {
          "label": "B",
          "text": "Endometroid with squamous differenciation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mucinous",
          "correct": false
        },
        {
          "label": "D",
          "text": "Serous",
          "correct": true
        }
      ],
      "correct_answer": "D. Serous",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/18/image.png",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/18/image_A9fgwQi.png"
      ],
      "explanation": "<p><strong>Ans. D. Serous</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Berek and novak, 16ed, page 2378</li><li>\u27a4 Ref: Berek and novak, 16ed, page 2378</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "639a999a",
      "audio": ""
    },
    {
      "text": "Most common simultaneously occurring malignancies are:",
      "options": [
        {
          "label": "A",
          "text": "Cervical and ovarian",
          "correct": false
        },
        {
          "label": "B",
          "text": "Cervical and GTN",
          "correct": false
        },
        {
          "label": "C",
          "text": "Endometrial and cervical",
          "correct": false
        },
        {
          "label": "D",
          "text": "Endometrial and ovarian cancer",
          "correct": true
        }
      ],
      "correct_answer": "D. Endometrial and ovarian cancer",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Endometrial and ovarian</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Synchronous endometrial and ovarian tumors are the most frequent simultaneously occurring genital tract malignancies.</li><li>\u27a4 Synchronous endometrial and ovarian tumors are the most frequent simultaneously occurring genital tract malignancies.</li><li>\u27a4 Ref: Berek and novak, 16ed, page 2381</li><li>\u27a4 Ref: Berek and novak, 16ed, page 2381</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "db4c0fdb",
      "audio": ""
    },
    {
      "text": "Most common type of epithelial ovarian tumors are:",
      "options": [
        {
          "label": "A",
          "text": "Clear cell",
          "correct": false
        },
        {
          "label": "B",
          "text": "Mucinous",
          "correct": false
        },
        {
          "label": "C",
          "text": "Serous",
          "correct": true
        },
        {
          "label": "D",
          "text": "Transitional",
          "correct": false
        }
      ],
      "correct_answer": "C. Serous",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image_v42aRtk.png"
      ],
      "explanation": "<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The commonest type of ovarian cancer is epithelial ovarian cancer, amongst which, serous type is most common</li><li>\u27a4 The commonest type of ovarian cancer is epithelial ovarian cancer, amongst which, serous type is most common</li><li>\u27a4 Ref: Berek & novak 16 ed, page 2547</li><li>\u27a4 Ref: Berek & novak 16 ed, page 2547</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8b5ba838",
      "audio": ""
    },
    {
      "text": "Match the ovarian tumors with the type of cell they resemble:",
      "options": [
        {
          "label": "A",
          "text": "1: d, 2: b, 3: a, 4: c",
          "correct": false
        },
        {
          "label": "B",
          "text": "1: b, 2: d, 3: a, 4: c",
          "correct": true
        },
        {
          "label": "C",
          "text": "1: a, 2: c, 3: b, 4: d",
          "correct": false
        },
        {
          "label": "D",
          "text": "1: c, 2: a, 3: b, 4: d",
          "correct": false
        }
      ],
      "correct_answer": "B. 1: b, 2: d, 3: a, 4: c",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-745.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-746.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-746.jpg"
      ],
      "explanation": "<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The histologic picture of different epithelial ovarian cancers resempble different epithelium as shown in the table below:</li><li>\u27a4 The histologic picture of different epithelial ovarian cancers resempble different epithelium as shown in the table below:</li><li>\u27a4 Ref: Berek & novak 16 ed, page 2547</li><li>\u27a4 Ref: Berek & novak 16 ed, page 2547</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7fa57262",
      "audio": ""
    },
    {
      "text": "Match the following:",
      "options": [
        {
          "label": "A",
          "text": "1b 2a 3d 4c",
          "correct": true
        },
        {
          "label": "B",
          "text": "1a 2b 3d 4c",
          "correct": false
        },
        {
          "label": "C",
          "text": "1d 2c 3a 4b",
          "correct": false
        },
        {
          "label": "D",
          "text": "1c 2d 3b 4a",
          "correct": false
        }
      ],
      "correct_answer": "A. 1b 2a 3d 4c",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/19/screenshot-2023-12-19-122614.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/19/screenshot-2023-12-19-122712.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/19/screenshot-2023-12-19-122043.jpg"
      ],
      "explanation": "<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Important HPE images in ovarian cancer:</li><li>\u27a4 Important HPE images in ovarian cancer:</li><li>\u27a4 Ref: berek and novak, 16 ed, chapter 39</li><li>\u27a4 Ref: berek and novak, 16 ed, chapter 39</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "27999353",
      "audio": ""
    },
    {
      "text": "A 25-year-old unmarried girl, whose mother died of ovarian cancer comes to you for advice regarding prevention of ovarian cancer. Which of the following will you suggest her for prevention of ovarian cancer:",
      "options": [
        {
          "label": "A",
          "text": "Bilateral mastectomy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Bilateral salpingo oophorectomy",
          "correct": false
        },
        {
          "label": "C",
          "text": "HPV vaccine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Oral contraceptive pill",
          "correct": true
        }
      ],
      "correct_answer": "D. Oral contraceptive pill",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Risk Factors for epithelial ovarian cancer</li><li>\u27a4 Risk Factors for epithelial ovarian cancer</li><li>\u27a4 Nulliparity Early menarche, late menopause White race Increasing age Family history Personal h/o breast cancer Ethnicity (European jews, Icelandic and Hungarian) Post menopausal HRT PID</li><li>\u27a4 Nulliparity</li><li>\u27a4 Nulliparity</li><li>\u27a4 Early menarche, late menopause</li><li>\u27a4 Early menarche, late menopause</li><li>\u27a4 White race</li><li>\u27a4 White race</li><li>\u27a4 Increasing age</li><li>\u27a4 Increasing age</li><li>\u27a4 Family history</li><li>\u27a4 Family history</li><li>\u27a4 Personal h/o breast cancer</li><li>\u27a4 Personal h/o breast cancer</li><li>\u27a4 Ethnicity (European jews, Icelandic and Hungarian)</li><li>\u27a4 Ethnicity (European jews, Icelandic and Hungarian)</li><li>\u27a4 Post menopausal HRT</li><li>\u27a4 Post menopausal HRT</li><li>\u27a4 PID</li><li>\u27a4 PID</li><li>\u27a4 Protective Factors for Ovarian cancer</li><li>\u27a4 Protective Factors for Ovarian cancer</li><li>\u27a4 B/l salpingectomy or tubal ligation Oophorectomy Combined OCP Pregnancy and breast feeding</li><li>\u27a4 B/l salpingectomy or tubal ligation</li><li>\u27a4 B/l salpingectomy or tubal ligation</li><li>\u27a4 Oophorectomy</li><li>\u27a4 Oophorectomy</li><li>\u27a4 Combined OCP</li><li>\u27a4 Combined OCP</li><li>\u27a4 Pregnancy and breast feeding</li><li>\u27a4 Pregnancy and breast feeding</li><li>\u27a4 Ref: berek and noval 16 edition, page 2561</li><li>\u27a4 Ref: berek and noval 16 edition, page 2561</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "767db255",
      "audio": ""
    },
    {
      "text": "Which of the following is FALSE regarding BRCA related hereditary ovarian cancer?",
      "options": [
        {
          "label": "A",
          "text": "Both BRCA1 and BRCA2 are associated with increased risk of ovarian cancer",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hereditary cancer tends to occur in women 10 years earlier than the non-hereditary ovarian cancers",
          "correct": false
        },
        {
          "label": "C",
          "text": "Most BRCA related ovarian cancers are high grade mucinous cancers",
          "correct": true
        },
        {
          "label": "D",
          "text": "Prophylactic salpingo oophorectomy reduces risk of BRCA related gynecological cancer by 95%",
          "correct": false
        }
      ],
      "correct_answer": "C. Most BRCA related ovarian cancers are high grade mucinous cancers",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The BRCA genes increase the risk of serous epithelial ovarian cancers and breast cancers BRCA1 gene is located on chromosome 17q21. Patients with a proven mutation have a dramatically elevated risk of developing ovarian cancer (About 40%). BRCA2 is located on chromosome 13q12 and in general is less likely to lead to ovarian cancer (12 to 20%). The estimated lifetime risk of breast cancer with a BRCA1 or BRCA2 mutation is 65 - 74 percent The only proven way to directly prevent ovarian cancer is surgical removal. In BRCA1 or BRCA2 carriers, prophylactic bilateral salpingo-oophorectomy (BSO) may be performed either upon completion of childbearing or by age 40 years</li><li>\u27a4 The BRCA genes increase the risk of serous epithelial ovarian cancers and breast cancers</li><li>\u27a4 BRCA1 gene is located on chromosome 17q21. Patients with a proven mutation have a dramatically elevated risk of developing ovarian cancer (About 40%).</li><li>\u27a4 BRCA2 is located on chromosome 13q12 and in general is less likely to lead to ovarian cancer (12 to 20%).</li><li>\u27a4 The estimated lifetime risk of breast cancer with a BRCA1 or BRCA2 mutation is 65 - 74 percent</li><li>\u27a4 The only proven way to directly prevent ovarian cancer is surgical removal.</li><li>\u27a4 In BRCA1 or BRCA2 carriers, prophylactic bilateral salpingo-oophorectomy (BSO) may be performed either upon completion of childbearing or by age 40 years</li><li>\u27a4 Ref: Berek and Novak 16 edition, pg 2566, Page 738, Williams Gynecology 3rd edition</li><li>\u27a4 Ref: Berek and Novak 16 edition, pg 2566, Page 738, Williams Gynecology 3rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "27afa8b9",
      "audio": ""
    },
    {
      "text": "A 50-year-old postmenopausal woman underwent staging laparotomy for ovarian malignancy. Intraoperatively, there was ascites present, 10*10 cm right ovarian cyst with an intact capsule, which ruptured during surgery to reveal solid areas, omentum had a 3*3cm deposit. The rest of abdominal organs were normal on palpation. On histopathology, ascites showed malignant cells, ovary had serous carcinoma and the omentum showed malignant cells. Lymph nodes were free of tumor cells. Which of the following is TRUE for the patient?",
      "options": [
        {
          "label": "A",
          "text": "Stage of the disease is I C3",
          "correct": false
        },
        {
          "label": "B",
          "text": "The surgery is staging laparotomy with bilateral salpingectomy with omentectomy with pelvic and paraaortic lymphadenectomy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Post operative chemotherapy will be required",
          "correct": true
        },
        {
          "label": "D",
          "text": "5-year Survival is around 70%",
          "correct": false
        }
      ],
      "correct_answer": "C. Post operative chemotherapy will be required",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/19/ovarian-cancer-staging-figo.jpg"
      ],
      "explanation": "<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The primary mode of treatment of ovarian cancer is SURGICAL STAGING (which involves removing the uterus and ovaries with debulking of tumor tissue) followed by CHEMOTHERAPY (Platinum based - Cisplatin or Carboplatin  + Paclitaxel)</li><li>\u27a4 The primary mode of treatment of ovarian cancer is SURGICAL STAGING (which involves removing the uterus and</li><li>\u27a4 ovaries with debulking of tumor tissue) followed by CHEMOTHERAPY (Platinum based - Cisplatin or Carboplatin  + Paclitaxel)</li><li>\u27a4 Ref: Berek and novak 16 edition, 2577 (page 2619)</li><li>\u27a4 Ref: Berek and novak 16 edition, 2577</li><li>\u27a4 (page 2619)</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4143bb66",
      "audio": ""
    },
    {
      "text": "A 52-year-old female has epithelial ovarian tumor which on evaluation has been found to be unresectable and planned for neoadjuvant chemotherapy. Which of the following is the most suitable drug/drug combination for her?",
      "options": [
        {
          "label": "A",
          "text": "Bleomycin etopocide cisplatin (BEP)",
          "correct": false
        },
        {
          "label": "B",
          "text": "Carboplatin paclitaxel (CP)",
          "correct": true
        },
        {
          "label": "C",
          "text": "EMACO",
          "correct": false
        },
        {
          "label": "D",
          "text": "Methotrexate",
          "correct": false
        }
      ],
      "correct_answer": "B. Carboplatin paclitaxel (CP)",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Neoadjuvant chemotherapy is an option for patients with advanced ovarian cancer who have a low likelihood of optimal cytoreduction/high perioperative risk. Carboplatin paclitaxel is the most commonly used chemotherapy for epithelial ovarian cancer.</li><li>\u27a4 Neoadjuvant chemotherapy is an option for patients with advanced ovarian cancer who have a low likelihood of optimal cytoreduction/high perioperative risk.</li><li>\u27a4 Carboplatin paclitaxel is the most commonly used chemotherapy for epithelial ovarian cancer.</li><li>\u27a4 Ref: Berek and novak 16 edition, 2600-02</li><li>\u27a4 Ref: Berek and novak 16 edition, 2600-02</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a02701fe",
      "audio": ""
    },
    {
      "text": "A patient presents to you with ovarian malignancy. Her CA 125 is 850 U/mL. Her MRI shows 15cm*15 cm ovarian mass along with omental caking. She is planned for staging laparotomy and adjuvant chemotherapy. Which of the following will have worst effect on the prognosis of the patient?",
      "options": [
        {
          "label": "A",
          "text": "Inability to prove ovarian malignancy by histopathology before staging laparotomy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Inability to attain complete cytoreduction during surgery",
          "correct": true
        },
        {
          "label": "C",
          "text": "Inability to start chemotherapy within 2 weeks of surgery",
          "correct": false
        },
        {
          "label": "D",
          "text": "Need to perform resection anastomosis of bowel to achieve complete cytoreduction",
          "correct": false
        }
      ],
      "correct_answer": "B. Inability to attain complete cytoreduction during surgery",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Complete cytoreduction is the most important factor associated with survival in advanced ovarian cancers. Need for Resection anastomosis does not worsen prognosis</li><li>\u27a4 Ref: Berek & novak 16 edition, page 2589</li><li>\u27a4 Ref: Berek & novak 16 edition, page 2589</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9fd926bd",
      "audio": ""
    },
    {
      "text": "Match the following:",
      "options": [
        {
          "label": "A",
          "text": "1b 2d 3c 4a",
          "correct": false
        },
        {
          "label": "B",
          "text": "1b 2c 3d 4a",
          "correct": true
        },
        {
          "label": "C",
          "text": "1a 2c 3b 4d",
          "correct": false
        },
        {
          "label": "D",
          "text": "1a 2d 3c 4b",
          "correct": false
        }
      ],
      "correct_answer": "B. 1b 2c 3d 4a",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-751.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-752.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-752.jpg"
      ],
      "explanation": "<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Remember the table for ovarian tumor markers. It is very very important</li><li>\u27a4 Remember the table for ovarian tumor markers. It is very very important</li><li>\u27a4 Ref: Berek and novak 16 ed, chapter 39</li><li>\u27a4 Ref: Berek and novak 16 ed, chapter 39</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "27999353",
      "audio": ""
    },
    {
      "text": "A 15-year-old girl presents with precocious puberty and solid ovarian mass suspected to be granulosa cell tumor. Which of the following is false regarding these tumors:",
      "options": [
        {
          "label": "A",
          "text": "Call exner bodiea are present",
          "correct": false
        },
        {
          "label": "B",
          "text": "Highly chemosensitive",
          "correct": false
        },
        {
          "label": "C",
          "text": "Level of Inhibin B is raised",
          "correct": false
        },
        {
          "label": "D",
          "text": "Precocious puberty is due to associated adrenal tumors",
          "correct": true
        }
      ],
      "correct_answer": "D. Precocious puberty is due to associated adrenal tumors",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Granulosa Cell Tumor of the Ovary:</li><li>\u27a4 Granulosa Cell Tumor of the Ovary:</li><li>\u27a4 Granulosa cell tumors: 2 percent of all ovarian neoplasms. Originates from the \u2018rests\u2019 of primitive granulosa cells unused in folliculogenesis. It is the commonest ovarian stromal tumor. It is bilateral in 2% The size varies, so also the consistency \u2014 may be solid or cystic. Cut section: yellow or orange due to its lipid content. Microscopic appearance: Coffee bean\u201d nuclei. S Call-Exner bodies: Pathognomonic of granulosa cell tumor. The tumor cells secrete inhibin, estrogen and AMH (tumor markers) As the tumor produces estrogen, there may be associated endometrial hyperplasia (50%) and unopposed estrogenic stimulation leads to development of endometrial carcinoma in about 5\u201310 percent of cases. Clinical features: It occurs in all ages, 10 percent prior to puberty, 40 percent during childbearing period and 50 percent in postmenopausal women. Prior to puberty: Precocious puberty Childbearing period: Abnormal uterine bleeding Postmenopausal: Bleeding Treatment: Laparotomy and surgical staging followed by chemotherapy is done. Unilateral salpingo-oophorectomy is the optimum treatment for children or women in the reproductive age.  BEP (Bleomycin, Etoposide and Cisplatin) is the chemotherapeutic regimens. It is a highly chemosensitive tumor.  Overall prognosis is good. Life time follow up is essential as recurrence can occur as late as 30 years</li><li>\u27a4 Granulosa cell tumors: 2 percent of all ovarian neoplasms.</li><li>\u27a4 Originates from the \u2018rests\u2019 of primitive granulosa cells unused in folliculogenesis.</li><li>\u27a4 It is the commonest ovarian stromal tumor.</li><li>\u27a4 It is bilateral in 2%</li><li>\u27a4 The size varies, so also the consistency \u2014 may be solid or cystic.</li><li>\u27a4 Cut section: yellow or orange due to its lipid content.</li><li>\u27a4 Microscopic appearance: Coffee bean\u201d nuclei. S Call-Exner bodies: Pathognomonic of granulosa cell tumor.</li><li>\u27a4 Coffee bean\u201d nuclei. S Call-Exner bodies: Pathognomonic of granulosa cell tumor.</li><li>\u27a4 Coffee bean\u201d nuclei. S</li><li>\u27a4 Call-Exner bodies: Pathognomonic of granulosa cell tumor.</li><li>\u27a4 The tumor cells secrete inhibin, estrogen and AMH (tumor markers)</li><li>\u27a4 As the tumor produces estrogen, there may be associated endometrial hyperplasia (50%) and unopposed estrogenic stimulation leads to development of endometrial carcinoma in about 5\u201310 percent of cases.</li><li>\u27a4 Clinical features: It occurs in all ages, 10 percent prior to puberty, 40 percent during childbearing period and 50 percent in postmenopausal women. Prior to puberty: Precocious puberty Childbearing period: Abnormal uterine bleeding Postmenopausal: Bleeding</li><li>\u27a4 It occurs in all ages, 10 percent prior to puberty, 40 percent during childbearing period and 50 percent in postmenopausal women. Prior to puberty: Precocious puberty Childbearing period: Abnormal uterine bleeding Postmenopausal: Bleeding</li><li>\u27a4 It occurs in all ages, 10 percent prior to puberty, 40 percent during childbearing period and 50 percent in postmenopausal women.</li><li>\u27a4 Prior to puberty: Precocious puberty</li><li>\u27a4 Childbearing period: Abnormal uterine bleeding</li><li>\u27a4 Postmenopausal: Bleeding</li><li>\u27a4 Treatment: Laparotomy and surgical staging followed by chemotherapy is done. Unilateral salpingo-oophorectomy is the optimum treatment for children or women in the reproductive age.  BEP (Bleomycin, Etoposide and Cisplatin) is the chemotherapeutic regimens. It is a highly chemosensitive tumor.  Overall prognosis is good. Life time follow up is essential as recurrence can occur as late as 30 years</li><li>\u27a4 Ref: Berek & novak, 16 ed, page 2646</li><li>\u27a4 Ref: Berek & novak, 16 ed, page 2646</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6fd23095",
      "audio": ""
    },
    {
      "text": "A 12-year-old girl presents with adnexal mass and undergoes unilateral salpingooophorectomy. Histopathology shows large clear cells with abundant cytoplasm, large nuclei with fibrous septae containing lymphocytic infiltrate as shown. Which of the following statements is TRUE?",
      "options": [
        {
          "label": "A",
          "text": "She has clear cell epithelial ovarian tumor",
          "correct": false
        },
        {
          "label": "B",
          "text": "LDH is likely to be increased",
          "correct": true
        },
        {
          "label": "C",
          "text": "She will require completion surgery with total abdominal hysterectomy and salpingooophorectomy",
          "correct": false
        },
        {
          "label": "D",
          "text": "These tumors are chemoresistant",
          "correct": false
        }
      ],
      "correct_answer": "B. LDH is likely to be increased",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-753.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Dysgerminoma</li><li>\u27a4 Dysgerminoma</li><li>\u27a4 Dysgerminoma is the commonest (30\u201340%) malignant germ cell tumor. It arises from undifferentiated form of germ cells. In 5%: Dysgenetic gonads so karyotype may be required The counterpart of dysgerminoma in male is seminoma. Majority (75%) of the tumors occur before the age of 30 years. Tumor marker is LDH Pathology: The shape is usually round or oval and is usually 5\u201315 cm in diameter; It is firm rubbery. It may be bilateral (10%). Cut section shows pink or yellow color. Microscopic appearance: uniform large round cells,  arranged in cords or clumps with abundant clear cytoplasm. Nuclei are large, irregular and hyperchromatic with varying degree of mitosis. There is intense infiltration of lymphocytes and plasma cells in the fibrous septum. Malignant in > 50% Clinical features:  not specific for the tumor. Treatment: Majority (75%) of dysgerminomas are confined to one ovary and are stage I at the time of diagnosis In a young patient where preservation of fertility is desired, laparotomy for surgical staging and unilateral salpingo-oophorectomy is done. If there is any suspicion of involvement to the other ovary, bisection of the contralateral ovary and excisional biopsy should be done. The tumor is sensitive to both chemotherapy and radiotherapy. BEP (Bleomycin, Etoposide and Cisplatin), VBP (Vinbla-stin, Bleomycin and Cisplatin), VAC (Vincristine, Actinomycin and Cyclophosphamide) are the commonly used drugs for the germ cell tumors.</li><li>\u27a4 Dysgerminoma is the commonest (30\u201340%) malignant germ cell tumor.</li><li>\u27a4 It arises from undifferentiated form of germ cells.</li><li>\u27a4 In 5%: Dysgenetic gonads so karyotype may be required</li><li>\u27a4 The counterpart of dysgerminoma in male is seminoma.</li><li>\u27a4 Majority (75%) of the tumors occur before the age of 30 years.</li><li>\u27a4 Tumor marker is LDH</li><li>\u27a4 Pathology: The shape is usually round or oval and is usually 5\u201315 cm in diameter; It is firm rubbery. It may be bilateral (10%). Cut section shows pink or yellow color.</li><li>\u27a4 Microscopic appearance: uniform large round cells,  arranged in cords or clumps with abundant clear cytoplasm. Nuclei are large, irregular and hyperchromatic with varying degree of mitosis. There is intense infiltration of lymphocytes and plasma cells in the fibrous septum. Malignant in > 50%</li><li>\u27a4 Clinical features:  not specific for the tumor.</li><li>\u27a4 Treatment: Majority (75%) of dysgerminomas are confined to one ovary and are stage I at the time of diagnosis In a young patient where preservation of fertility is desired, laparotomy for surgical staging and unilateral salpingo-oophorectomy is done. If there is any suspicion of involvement to the other ovary, bisection of the contralateral ovary and excisional biopsy should be done. The tumor is sensitive to both chemotherapy and radiotherapy. BEP (Bleomycin, Etoposide and Cisplatin), VBP (Vinbla-stin, Bleomycin and Cisplatin), VAC (Vincristine, Actinomycin and Cyclophosphamide) are the commonly used drugs for the germ cell tumors.</li><li>\u27a4 Majority (75%) of dysgerminomas are confined to one ovary and are stage I at the time of diagnosis In a young patient where preservation of fertility is desired, laparotomy for surgical staging and unilateral salpingo-oophorectomy is done. If there is any suspicion of involvement to the other ovary, bisection of the contralateral ovary and excisional biopsy should be done. The tumor is sensitive to both chemotherapy and radiotherapy. BEP (Bleomycin, Etoposide and Cisplatin), VBP (Vinbla-stin, Bleomycin and Cisplatin), VAC (Vincristine, Actinomycin and Cyclophosphamide) are the commonly used drugs for the germ cell tumors.</li><li>\u27a4 Majority (75%) of dysgerminomas are confined to one ovary and are stage I at the time of diagnosis In a young patient where preservation of fertility is desired, laparotomy for surgical staging and unilateral salpingo-oophorectomy is done.</li><li>\u27a4 If there is any suspicion of involvement to the other ovary, bisection of the contralateral ovary and excisional biopsy should be done.</li><li>\u27a4 The tumor is sensitive to both chemotherapy and radiotherapy.</li><li>\u27a4 BEP (Bleomycin, Etoposide and Cisplatin), VBP (Vinbla-stin, Bleomycin and Cisplatin), VAC (Vincristine, Actinomycin and Cyclophosphamide) are the commonly used drugs for the germ cell tumors.</li><li>\u27a4 Ref: Berek & novak, 16 ed, page 2624-33.</li><li>\u27a4 Ref: Berek & novak, 16 ed, page 2624-33.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a152724a",
      "audio": ""
    },
    {
      "text": "Identify the tumor in which this HPE finding is likely?",
      "options": [
        {
          "label": "A",
          "text": "Granulosa cell tumor",
          "correct": false
        },
        {
          "label": "B",
          "text": "Yolk sac tumor",
          "correct": true
        },
        {
          "label": "C",
          "text": "Dysgerminoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Dermoid tumor",
          "correct": false
        }
      ],
      "correct_answer": "B. Yolk sac tumor",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-754.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4fe95494",
      "audio": ""
    },
    {
      "text": "Identify the histopathological finding:",
      "options": [
        {
          "label": "A",
          "text": "Schiller duval body",
          "correct": false
        },
        {
          "label": "B",
          "text": "Call exner body",
          "correct": true
        },
        {
          "label": "C",
          "text": "Psammoma body",
          "correct": false
        },
        {
          "label": "D",
          "text": "Leydig cells",
          "correct": false
        }
      ],
      "correct_answer": "B. Call exner body",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-755.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image-20231217194937-1.jpeg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image-20231217195106-2.jpeg",
        "https://i.pinimg.com/originals/c9/6d/c6/c96dc66188b5b9a7f415b4a541503e09.png"
      ],
      "explanation": "<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1ba12d91",
      "audio": ""
    },
    {
      "text": "A 30-year-old woman presents to you as she recently found out that her aunt passed away from breast cancer. Her mother had passed away from ovarian cancer 10 years of ago. What is the next best step:",
      "options": [
        {
          "label": "A",
          "text": "Offer BRCA testing",
          "correct": true
        },
        {
          "label": "B",
          "text": "Offer bilateral salpingooophorectomy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Offer CA 125 measurement",
          "correct": false
        },
        {
          "label": "D",
          "text": "Offer bilateral mastectomy",
          "correct": false
        }
      ],
      "correct_answer": "A. Offer BRCA testing",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/19/screenshot-2023-12-19-162846.jpg"
      ],
      "explanation": "<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 BRCA testing should be offered to women with:</li><li>\u27a4 BRCA testing should be offered to women with:</li><li>\u27a4 Ref: Berek and novak, 16 ed 2564</li><li>\u27a4 Ref: Berek and novak, 16 ed 2564</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0931610c",
      "audio": ""
    },
    {
      "text": "Identify the tumor in the image:",
      "options": [
        {
          "label": "A",
          "text": "Granulosa cell tumor",
          "correct": false
        },
        {
          "label": "B",
          "text": "Endometriotic cyst",
          "correct": false
        },
        {
          "label": "C",
          "text": "Dermoid",
          "correct": true
        },
        {
          "label": "D",
          "text": "Yolk sac tumor",
          "correct": false
        }
      ],
      "correct_answer": "C. Dermoid",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-756.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image-20231217201516-1.jpeg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image-20231217201807-2.jpeg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/17/image-20231217201941-3.jpeg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/untitled-756.jpg"
      ],
      "explanation": "<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 This is the typical gross pathological image of an ovarian dermoid</li><li>\u27a4 This is the typical gross pathological image of an ovarian dermoid</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "326659e1",
      "audio": ""
    },
    {
      "text": "A 34-year-old woman presents to emergency with complaint of 2 months of amenorrhea with bleeding associated with passage of grape like clear vesicles. The likely diagnosis is:",
      "options": [
        {
          "label": "A",
          "text": "Complete abortion",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ectopic pregnancy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Incomplete abortion",
          "correct": false
        },
        {
          "label": "D",
          "text": "Molar pregnancy",
          "correct": true
        }
      ],
      "correct_answer": "D. Molar pregnancy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Molar pregnancy</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The classic presentation of molar pregnancy is a h/o amenorrhoea with a positive UPT with bleeding with passage of typical grape like vesicles \u200b\u200b\u200b\u200b\u200b\u200b\u200b</li><li>\u27a4 Ref: William\u2019s obstetrics, 26 th edition, chapter 13</li><li>\u27a4 Ref: William\u2019s obstetrics, 26 th edition, chapter 13</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a6828268",
      "audio": ""
    },
    {
      "text": "A 20-year-old woman presents to emergency with 3 months amenorrhea and passage of vesicles as shown in image. The woman most likely has:",
      "options": [
        {
          "label": "A",
          "text": "Complete abortion",
          "correct": false
        },
        {
          "label": "B",
          "text": "Ectopic pregnancy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Incomplete abortion",
          "correct": false
        },
        {
          "label": "D",
          "text": "Molar pregnancy",
          "correct": true
        }
      ],
      "correct_answer": "D. Molar pregnancy",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/1_KaBmanQ.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/2_9PK5kpJ.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/12/image.png"
      ],
      "explanation": "<p><strong>Ans. D. Molar pregnancy</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The first image is the classical image of grape like vesicles seen in complete molar pregnancy The second image is the HPE of complete molar pregnancy showing diffuse trophoblastic proliferation and diffuse villous edema</li><li>\u27a4 The first image is the classical image of grape like vesicles seen in complete molar pregnancy</li><li>\u27a4 The second image is the HPE of complete molar pregnancy showing diffuse trophoblastic proliferation and diffuse villous edema</li><li>\u27a4 Ref: William\u2019s obstetrics, 26 th edition, chapter 13</li><li>\u27a4 Ref: William\u2019s obstetrics, 26 th edition, chapter 13</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "29c3751b",
      "audio": ""
    },
    {
      "text": "A woman presents to emergency with amenorrhea, bleeding and passage of clear vesicles. She undergoes suction evacuation. The definitive diagnosis of molar pregnancy is made by:",
      "options": [
        {
          "label": "A",
          "text": "Clinical history of passage of clear vesicles",
          "correct": false
        },
        {
          "label": "B",
          "text": "Histological features showing hydropic changes in villi/ trophoblastic proliferation",
          "correct": true
        },
        {
          "label": "C",
          "text": "Increased beta hCG levels",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ultrasound feature of snowstorm appearance",
          "correct": false
        }
      ],
      "correct_answer": "B. Histological features showing hydropic changes in villi/ trophoblastic proliferation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Histological features showing hydropic changes in villi/ trophoblastic proliferation</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 HPE features consistent with the diagnosis of complete molar pregnancies include: Absence of fetal tissue Extensive hydropic change to the villi Excess trophoblast proliferation. \u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b HPE Features of a partial molar pregnancy include: Presence of fetal tissue Focal hydropic change to the villi Excess trophoblast proliferation</li><li>\u27a4 HPE features consistent with the diagnosis of complete molar pregnancies include: Absence of fetal tissue Extensive hydropic change to the villi Excess trophoblast proliferation. \u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b</li><li>\u27a4 Absence of fetal tissue Extensive hydropic change to the villi Excess trophoblast proliferation. \u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b</li><li>\u27a4 Absence of fetal tissue</li><li>\u27a4 Extensive hydropic change to the villi</li><li>\u27a4 Excess trophoblast proliferation. \u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b\u200b</li><li>\u27a4 HPE Features of a partial molar pregnancy include: Presence of fetal tissue Focal hydropic change to the villi Excess trophoblast proliferation</li><li>\u27a4 Presence of fetal tissue Focal hydropic change to the villi Excess trophoblast proliferation</li><li>\u27a4 Presence of fetal tissue</li><li>\u27a4 Focal hydropic change to the villi</li><li>\u27a4 Excess trophoblast proliferation</li><li>\u27a4 Ref: Management of Gestational Trophoblastic Disease</li><li>\u27a4 Green-top Guideline No. 38 \u2013 June 2020</li><li>\u27a4 Green-top Guideline No. 38 \u2013 June 2020</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f5fe254d",
      "audio": ""
    },
    {
      "text": "A 19-year-old primigravida presents to OPD with amenorrhea of 2.5 months, positive urine pregnancy test and bleeding per vagina. Her ultrasound image is shown below. She is most likely a case of:",
      "options": [
        {
          "label": "A",
          "text": "Complete abortion",
          "correct": false
        },
        {
          "label": "B",
          "text": "Complete mole",
          "correct": true
        },
        {
          "label": "C",
          "text": "Incomplete abortion",
          "correct": false
        },
        {
          "label": "D",
          "text": "Partial mole",
          "correct": false
        }
      ],
      "correct_answer": "B. Complete mole",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/3_4G8fevK.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/12/image_Rs9hSOQ.png",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/12/image_Rs9hSOQ.png"
      ],
      "explanation": "<p><strong>Ans. B. Complete mole</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The characteristic feature on ultrasound of a complete mole is as shown: SNOWSTORM APPEARANCE</li><li>\u27a4 The characteristic feature on ultrasound of a complete mole is as shown: SNOWSTORM APPEARANCE</li><li>\u27a4 Ref: William\u2019s obstetrics, 26 th edition, chapter 13,</li><li>\u27a4 Ref: William\u2019s obstetrics, 26 th edition, chapter 13,</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cd25f848",
      "audio": ""
    },
    {
      "text": "A patient visits for ultrasound at 18 weeks, which shows fetus with syndactyly with multicystic placenta as shown below. The most likely cause is:",
      "options": [
        {
          "label": "A",
          "text": "Parvovirus infection",
          "correct": false
        },
        {
          "label": "B",
          "text": "Partial mole",
          "correct": true
        },
        {
          "label": "C",
          "text": "Rh incompatibility",
          "correct": false
        },
        {
          "label": "D",
          "text": "Smoking in pregnancy",
          "correct": false
        }
      ],
      "correct_answer": "B. Partial mole",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/5_OvTET0e.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/12/image_42AWskL.png",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/12/image_lkerIzt.png"
      ],
      "explanation": "<p><strong>Ans. B. Partial mole</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 On ultrasound an complete mole will have a snowstorm pappearance A partial mole will have a cystic looking placenta with partial fetal parts seen</li><li>\u27a4 On ultrasound an complete mole will have a snowstorm pappearance</li><li>\u27a4 A partial mole will have a cystic looking placenta with partial fetal parts seen</li><li>\u27a4 Ref: Berek and Novak, 16 th edition, page 2762</li><li>\u27a4 Ref: Berek and Novak, 16 th edition, page 2762</li><li>\u27a4 William\u2019s obstetrics, 26 th edition, chapter 13,</li><li>\u27a4 William\u2019s obstetrics, 26 th edition, chapter 13,</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d183f5ac",
      "audio": ""
    },
    {
      "text": "Identify the ultrasound finding:",
      "options": [
        {
          "label": "A",
          "text": "Ring of Pearls appearance",
          "correct": false
        },
        {
          "label": "B",
          "text": "Rokitansky nodule",
          "correct": false
        },
        {
          "label": "C",
          "text": "Snowstorm appearance",
          "correct": true
        },
        {
          "label": "D",
          "text": "Waterlily sign",
          "correct": false
        }
      ],
      "correct_answer": "C. Snowstorm appearance",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/7_UoFonTd.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/12/image_5smKygV.png"
      ],
      "explanation": "<p><strong>Ans. C. Snowstorm appearance</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Snowstorm appearance is characteristically seen in complete mole on ultrasound</li><li>\u27a4 Snowstorm appearance is characteristically seen in complete mole on ultrasound</li><li>\u27a4 Snowstorm appearance is characteristically seen in complete mole on ultrasound</li><li>\u27a4 Ref: William\u2019s textbook of obstetrics, 26 edition, chapter 13.</li><li>\u27a4 Ref: William\u2019s textbook of obstetrics, 26 edition, chapter 13.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fe00cc14",
      "audio": ""
    },
    {
      "text": "A 20 year old woman undergoes suction evacuation for molar pregnancy. Histopathology features are suggestive of complete mole. Regarding karyotype of the tissue, which of the following is most likely:",
      "options": [
        {
          "label": "A",
          "text": "46XX, of maternal and paternal origin",
          "correct": false
        },
        {
          "label": "B",
          "text": "46XX, of paternal origin only",
          "correct": true
        },
        {
          "label": "C",
          "text": "69XXY, of maternal and paternal origin",
          "correct": false
        },
        {
          "label": "D",
          "text": "69XXY, of paternal origin only",
          "correct": false
        }
      ],
      "correct_answer": "B. 46XX, of paternal origin only",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. 46XX of paternal origin only</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Partial moles are always TRIPLOD (69XXX/ 69 XXY) 2 sperm fertilize one ova The paternal contribution is called diandry Hence both maternal and paternal component present in partial mole Usually, 69XXX or 69XXY Complete moles are DIPLOID Formed by either 1 sperm fertilizing an empty/ inactivated ova and then undergoes duplication \u2013 this is called androgenesis OR 2 sperms (dispermy) fertilize an empty/ inactivated ovum 46XX or 46XY Only paternal component; No maternal component</li><li>\u27a4 Partial moles are always TRIPLOD (69XXX/ 69 XXY) 2 sperm fertilize one ova The paternal contribution is called diandry Hence both maternal and paternal component present in partial mole Usually, 69XXX or 69XXY</li><li>\u27a4 TRIPLOD (69XXX/ 69 XXY)</li><li>\u27a4 2 sperm fertilize one ova The paternal contribution is called diandry Hence both maternal and paternal component present in partial mole Usually, 69XXX or 69XXY</li><li>\u27a4 2 sperm fertilize one ova</li><li>\u27a4 The paternal contribution is called diandry</li><li>\u27a4 diandry</li><li>\u27a4 Hence both maternal and paternal component present in partial mole</li><li>\u27a4 both maternal and paternal component</li><li>\u27a4 Usually, 69XXX or 69XXY</li><li>\u27a4 Complete moles are DIPLOID Formed by either 1 sperm fertilizing an empty/ inactivated ova and then undergoes duplication \u2013 this is called androgenesis OR 2 sperms (dispermy) fertilize an empty/ inactivated ovum 46XX or 46XY Only paternal component; No maternal component</li><li>\u27a4 DIPLOID</li><li>\u27a4 Formed by either 1 sperm fertilizing an empty/ inactivated ova and then undergoes duplication \u2013 this is called androgenesis OR 2 sperms (dispermy) fertilize an empty/ inactivated ovum 46XX or 46XY Only paternal component; No maternal component</li><li>\u27a4 Formed by either 1 sperm fertilizing an empty/ inactivated ova and then undergoes duplication \u2013 this is called androgenesis OR 2 sperms (dispermy) fertilize an empty/ inactivated ovum</li><li>\u27a4 androgenesis OR</li><li>\u27a4 46XX or 46XY</li><li>\u27a4 Only paternal component; No maternal component</li><li>\u27a4 Only paternal component;</li><li>\u27a4 No maternal component</li><li>\u27a4 Ref: Berek and Novak, 16 th edition, page 2760</li><li>\u27a4 Ref: Berek and Novak, 16 th edition, page 2760</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3d08dd13",
      "audio": ""
    },
    {
      "text": "A 21-year-old woman presented to emergency with 3 months pregnancy and bleeding per vaginum. She underwent suction evacuation for suspected molar pregnancy. Histopathology confirmed the diagnosis and showed scalloping of chorionic villi. The karyotype is likely to be:",
      "options": [
        {
          "label": "A",
          "text": "46XX",
          "correct": false
        },
        {
          "label": "B",
          "text": "46XY",
          "correct": false
        },
        {
          "label": "C",
          "text": "69XXX",
          "correct": true
        },
        {
          "label": "D",
          "text": "69YYY",
          "correct": false
        }
      ],
      "correct_answer": "C. 69XXX",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. 69 XXX</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Partial moles are always TRIPLOD (69XXX/ 69 XXY) 2 sperm fertilize one ova The paternal contribution is called diandry Hence both maternal and paternal component present in partial mole Usually, 69XXX or 69XXY Complete moles are DIPLOID Formed by either 1 sperm fertilizing an empty/ inactivated ova and then undergoes duplication \u2013 this is called androgenesis OR 2 sperms (dispermy) fertilize an empty/ inactivated ovum 46XX or 46XY Only paternal component; No maternal component</li><li>\u27a4 Partial moles are always TRIPLOD (69XXX/ 69 XXY) 2 sperm fertilize one ova The paternal contribution is called diandry Hence both maternal and paternal component present in partial mole Usually, 69XXX or 69XXY</li><li>\u27a4 TRIPLOD (69XXX/ 69 XXY)</li><li>\u27a4 2 sperm fertilize one ova The paternal contribution is called diandry Hence both maternal and paternal component present in partial mole Usually, 69XXX or 69XXY</li><li>\u27a4 2 sperm fertilize one ova</li><li>\u27a4 The paternal contribution is called diandry</li><li>\u27a4 diandry</li><li>\u27a4 Hence both maternal and paternal component present in partial mole</li><li>\u27a4 both maternal and paternal component</li><li>\u27a4 Usually, 69XXX or 69XXY</li><li>\u27a4 Complete moles are DIPLOID Formed by either 1 sperm fertilizing an empty/ inactivated ova and then undergoes duplication \u2013 this is called androgenesis OR 2 sperms (dispermy) fertilize an empty/ inactivated ovum 46XX or 46XY Only paternal component; No maternal component</li><li>\u27a4 DIPLOID</li><li>\u27a4 Formed by either 1 sperm fertilizing an empty/ inactivated ova and then undergoes duplication \u2013 this is called androgenesis OR 2 sperms (dispermy) fertilize an empty/ inactivated ovum 46XX or 46XY Only paternal component; No maternal component</li><li>\u27a4 Formed by either 1 sperm fertilizing an empty/ inactivated ova and then undergoes duplication \u2013 this is called androgenesis OR 2 sperms (dispermy) fertilize an empty/ inactivated ovum</li><li>\u27a4 androgenesis OR</li><li>\u27a4 46XX or 46XY</li><li>\u27a4 Only paternal component; No maternal component</li><li>\u27a4 Only paternal component;</li><li>\u27a4 No maternal component</li><li>\u27a4 Ref: Berek and  Novak 16 edition page 2764</li><li>\u27a4 Ref: Berek and  Novak 16 edition page 2764</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "24412f81",
      "audio": ""
    },
    {
      "text": "A woman presents to emergency ward with 5 months of amenorrhea and bleeding PV, her fundal height is 18 weeks, but external ballotment is absent. USG shown snowstorm appearance. What is the best management option for her:",
      "options": [
        {
          "label": "A",
          "text": "Chemotherapy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hysterotomy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Suction evacuation",
          "correct": true
        },
        {
          "label": "D",
          "text": "Uterine artery embolization",
          "correct": false
        }
      ],
      "correct_answer": "C. Suction evacuation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Suction evacuation</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The management of choice in a mplar pregnancy is suction and evacuation, irrespective of the uterine size.</li><li>\u27a4 The management of choice in a mplar pregnancy is suction and evacuation, irrespective of the uterine size.</li><li>\u27a4 The management of choice in a mplar pregnancy is suction and evacuation, irrespective of the uterine size.</li><li>\u27a4 Ref: berek and novak, 16 th edition: page 2770</li><li>\u27a4 Ref: berek and novak, 16 th edition: page 2770</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f7dc6d3e",
      "audio": ""
    },
    {
      "text": "Which of the following marker is likely to be raised in molar pregnancy:",
      "options": [
        {
          "label": "A",
          "text": "CA 125",
          "correct": false
        },
        {
          "label": "B",
          "text": "hCG",
          "correct": true
        },
        {
          "label": "C",
          "text": "Inhibin A",
          "correct": false
        },
        {
          "label": "D",
          "text": "PAPPA",
          "correct": false
        }
      ],
      "correct_answer": "B. hCG",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. hCG</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Beta hCG is a critical marker for GTD and its values are raised in molar pregnancy Beta hCG is higher in complete moles (> 100,000) than partial mole</li><li>\u27a4 Beta hCG is a critical marker for GTD and its values are raised in molar pregnancy</li><li>\u27a4 Beta hCG is higher in complete moles (> 100,000) than partial mole</li><li>\u27a4 Ref: berek and novak, 16 th edition: page 2757</li><li>\u27a4 Ref: berek and novak, 16 th edition: page 2757</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "80004940",
      "audio": ""
    },
    {
      "text": "Which of the following statements is true in relation to P57 immunostaining in molar pregnancy:",
      "options": [
        {
          "label": "A",
          "text": "Absent in complete mole as it is maternal in origin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Absent in complete mole as it is paternal in origin",
          "correct": true
        },
        {
          "label": "C",
          "text": "Present in complete mole as it is maternal in origin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Present in complete mole as it is paternal in origin",
          "correct": false
        }
      ],
      "correct_answer": "B. Absent in complete mole as it is paternal in origin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Absent in complete mole as it is paternal in origin</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 p57KIP2 is a nuclear protein which is maternally expressed and hence present in partial moles (on immunohistochemstry) as partial moles have a maternal component It is absent in complete moles</li><li>\u27a4 p57KIP2 is a nuclear protein which is maternally expressed and hence present in partial moles (on immunohistochemstry) as partial moles have a maternal component</li><li>\u27a4 It is absent in complete moles</li><li>\u27a4 Ref: William\u2019s obstetrics 26 th edition, chapter 13.</li><li>\u27a4 Ref: William\u2019s obstetrics 26 th edition, chapter 13.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "be4d96e7",
      "audio": ""
    },
    {
      "text": "You are posted in gynaecology ward and sending investigations for a woman with molar pregnancy. Her hCG level is >1,00,000. Her TSH levels are likely to be:",
      "options": [
        {
          "label": "A",
          "text": "Decreased",
          "correct": true
        },
        {
          "label": "B",
          "text": "Increased",
          "correct": false
        },
        {
          "label": "C",
          "text": "Unchanged",
          "correct": false
        },
        {
          "label": "D",
          "text": "Can be increased or decreased depending upon complete/ partial mole",
          "correct": false
        }
      ],
      "correct_answer": "A. Decreased",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Decreased</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Hyperthyroidism is observed in 7% patients with complete mole. Elevated free T3, T4 levels and raised TSH is seen in such patients This is because of the similarity betwen hCG and TSH so an increased hCG causes increased production of thyroxine and this causes a negative feedback on TSH</li><li>\u27a4 Hyperthyroidism is observed in 7% patients with complete mole.</li><li>\u27a4 Elevated free T3, T4 levels and raised TSH is seen in such patients</li><li>\u27a4 This is because of the similarity betwen hCG and TSH so an increased hCG causes increased production of thyroxine and this causes a negative feedback on TSH</li><li>\u27a4 Ref: Berek and Novak 16 edition, page 2767</li><li>\u27a4 Ref: Berek and Novak 16 edition, page 2767</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "254988be",
      "audio": ""
    },
    {
      "text": "A woman with molar pregnancy is undergoing suction evacuation. Suddenly she develops breathing difficulty, tachypnoea and fall in saturation. The most likely cause is:",
      "options": [
        {
          "label": "A",
          "text": "Fluid overload",
          "correct": false
        },
        {
          "label": "B",
          "text": "Metastatic disease suggestive of GTN",
          "correct": false
        },
        {
          "label": "C",
          "text": "Thyroid storm",
          "correct": false
        },
        {
          "label": "D",
          "text": "Trophoblastic embolization",
          "correct": true
        }
      ],
      "correct_answer": "D. Trophoblastic embolization",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Trophoblastic embolization</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Respiratory distress sometimes occurs in patients with a complete mole. It is usually diagnosed in patients with excessive uterine size and markedly elevated T hese patients may have chest pain, dyspnea, tachypnea, and tachycardia and may experience severe respiratory distress during and after molar evacuation. Auscultation of the chest usually reveals diffuse rales, and chest radiographic evaluation may show bilateral pulmonary infiltrates. Respiratory distress usually resolves within 72 hours with cardiopulmonary support. In some circumstances, patients may require mechanical ventilation</li><li>\u27a4 Respiratory distress sometimes occurs in patients with a complete mole.</li><li>\u27a4 It is usually diagnosed in patients with excessive uterine size and markedly elevated</li><li>\u27a4 T hese patients may have chest pain, dyspnea, tachypnea, and tachycardia and may experience severe respiratory distress during and after molar evacuation.</li><li>\u27a4 Auscultation of the chest usually reveals diffuse rales, and chest radiographic evaluation may show bilateral pulmonary infiltrates.</li><li>\u27a4 Respiratory distress usually resolves within 72 hours with cardiopulmonary support. In some circumstances, patients may require mechanical ventilation</li><li>\u27a4 Ref: Berek and Novak, 16 th edition. 2767</li><li>\u27a4 Ref: Berek and Novak, 16 th edition. 2767</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "214a0fd0",
      "audio": ""
    },
    {
      "text": "Identify the instrument:",
      "options": [
        {
          "label": "A",
          "text": "Curette",
          "correct": false
        },
        {
          "label": "B",
          "text": "Karman cannula",
          "correct": true
        },
        {
          "label": "C",
          "text": "Manual vacuum aspiration syringe",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pipelle suction curette",
          "correct": false
        }
      ],
      "correct_answer": "B. Karman cannula",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/8_K4h83MU.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/16/image-20231216100447-1.png",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/16/image-20231216100544-2.jpeg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/16/image-20231216100644-3.jpeg"
      ],
      "explanation": "<p><strong>Ans. B. Karman cannula</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 It is a plastic disposable cannula which ic color coded (based on the diameter) It is used with the Manual Vacuum Aspiration (MVA) syringe to evacuate products of conception in Surgical MTP < 12 weks Incomplete abortion Inevitable abortion Molar pregnancy</li><li>\u27a4 It is a plastic disposable cannula which ic color coded (based on the diameter)</li><li>\u27a4 It is used with the Manual Vacuum Aspiration (MVA) syringe to evacuate products of conception in Surgical MTP < 12 weks Incomplete abortion Inevitable abortion Molar pregnancy</li><li>\u27a4 Surgical MTP < 12 weks Incomplete abortion Inevitable abortion Molar pregnancy</li><li>\u27a4 Surgical MTP < 12 weks</li><li>\u27a4 Incomplete abortion</li><li>\u27a4 Inevitable abortion</li><li>\u27a4 Molar pregnancy</li><li>\u27a4 Ref: Berek and Novak, 16 th edition, page 2770</li><li>\u27a4 Ref: Berek and Novak, 16 th edition, page 2770</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "636ab3e0",
      "audio": ""
    },
    {
      "text": "A woman underwent suction evacuation for complete mole. She was on weekly hCG follow up which has now returned to normal. What will be your advise to her for further follow up:",
      "options": [
        {
          "label": "A",
          "text": "No further follow up required",
          "correct": false
        },
        {
          "label": "B",
          "text": "Till One more negative value 1 month later",
          "correct": false
        },
        {
          "label": "C",
          "text": "Monthly follow up for 6 months",
          "correct": true
        },
        {
          "label": "D",
          "text": "Monthly follow up for 1 year",
          "correct": false
        }
      ],
      "correct_answer": "C. Monthly follow up for 6 months",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Monthly follow up for 6 months</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Post Evacuation Surveillance of molar pregnancy Risk of progression to GTN is higher following complete mole (15%) than partial mole (5%) Surveillance is done by serial measurement of \u03b2 hCG to detect persistent/ renewed trophoblastic proliferation. The initial baseline value is taken 2 days post evacuation Then weekly  beta hCGS are done till negative (This ususlaly takes 7 weeks for partial mole; 9 weeks for complete mole) Once beta hCG is negative on weekly measurements, it is measured monthly for 6 months</li><li>\u27a4 Post Evacuation Surveillance of molar pregnancy</li><li>\u27a4 Post Evacuation Surveillance of molar pregnancy</li><li>\u27a4 Risk of progression to GTN is higher following complete mole (15%) than partial mole (5%)</li><li>\u27a4 Surveillance is done by serial measurement of \u03b2 hCG to detect persistent/ renewed trophoblastic proliferation.</li><li>\u27a4 The initial baseline value is taken 2 days post evacuation</li><li>\u27a4 Then weekly  beta hCGS are done till negative (This ususlaly takes 7 weeks for partial mole; 9 weeks for complete mole)</li><li>\u27a4 Once beta hCG is negative on weekly measurements, it is measured monthly for 6 months</li><li>\u27a4 Ref: FIGO cancer report, 2021</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f2ae389c",
      "audio": ""
    },
    {
      "text": "A woman underwent suction evacuation and histopathology shows complete mole. She was kept on weekly hCG follow up. Her hCG returned to normal in 6 weeks. What is further plan for follow up:",
      "options": [
        {
          "label": "A",
          "text": "No further follow up required",
          "correct": false
        },
        {
          "label": "B",
          "text": "One more follow up 1 month later (if negative stop follow up)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Monthly follow up for 6 months, from date of evacuation",
          "correct": false
        },
        {
          "label": "D",
          "text": "Monthly follow up for 6 months, from date of normalization",
          "correct": true
        }
      ],
      "correct_answer": "D. Monthly follow up for 6 months, from date of normalization",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D . Monthly follow up for 6 months, from date of normalization</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Post Evacuation Surveillance of molar pregnancy Risk of progression to GTN is higher following complete mole (15%) than partial mole (5%) Surveillance is done by serial measurement of \u03b2 hCG to detect persistent/ renewed trophoblastic proliferation. The initial baseline value is taken 2 days post evacuation Then weekly  beta hCGS are done till negative (This ususlaly takes 7 weeks for partial mole; 9 weeks for complete mole) Once beta hCG is negative on weekly measurements, it is measured monthly for 6 months</li><li>\u27a4 Post Evacuation Surveillance of molar pregnancy Risk of progression to GTN is higher following complete mole (15%) than partial mole (5%) Surveillance is done by serial measurement of \u03b2 hCG to detect persistent/ renewed trophoblastic proliferation. The initial baseline value is taken 2 days post evacuation Then weekly  beta hCGS are done till negative (This ususlaly takes 7 weeks for partial mole; 9 weeks for complete mole) Once beta hCG is negative on weekly measurements, it is measured monthly for 6 months</li><li>\u27a4 Post Evacuation Surveillance of molar pregnancy</li><li>\u27a4 Risk of progression to GTN is higher following complete mole (15%) than partial mole (5%) Surveillance is done by serial measurement of \u03b2 hCG to detect persistent/ renewed trophoblastic proliferation. The initial baseline value is taken 2 days post evacuation Then weekly  beta hCGS are done till negative (This ususlaly takes 7 weeks for partial mole; 9 weeks for complete mole) Once beta hCG is negative on weekly measurements, it is measured monthly for 6 months</li><li>\u27a4 Risk of progression to GTN is higher following complete mole (15%) than partial mole (5%)</li><li>\u27a4 Surveillance is done by serial measurement of \u03b2 hCG to detect persistent/ renewed trophoblastic proliferation.</li><li>\u27a4 The initial baseline value is taken 2 days post evacuation</li><li>\u27a4 Then weekly  beta hCGS are done till negative (This ususlaly takes 7 weeks for partial mole; 9 weeks for complete mole)</li><li>\u27a4 Once beta hCG is negative on weekly measurements, it is measured monthly for 6 months</li><li>\u27a4 Ref: figo cancer report, 2021</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "964a6265",
      "audio": ""
    },
    {
      "text": "You are counselling a patient regarding management of molar pregnancy. Which of the following contraceptive is contraindicated in patients after evacuation for molar pregnancy:",
      "options": [
        {
          "label": "A",
          "text": "Barrier methods",
          "correct": false
        },
        {
          "label": "B",
          "text": "Copper T",
          "correct": true
        },
        {
          "label": "C",
          "text": "Injection DMPA",
          "correct": false
        },
        {
          "label": "D",
          "text": "Oral contraceptive pills",
          "correct": false
        }
      ],
      "correct_answer": "B. Copper T",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Copper T</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Post molar evacuation, contraception is advised till the period of beta hCG surveillance All contraceptives are safe except Intra-Uterine Devices. Combined OCPs can be started after beta hCG values return to normal</li><li>\u27a4 Post molar evacuation, contraception is advised till the period of beta hCG surveillance</li><li>\u27a4 Post molar evacuation, contraception is advised till the period of beta hCG surveillance</li><li>\u27a4 All contraceptives are safe except Intra-Uterine Devices.</li><li>\u27a4 All contraceptives are safe except Intra-Uterine Devices.</li><li>\u27a4 Combined OCPs can be started after beta hCG values return to normal</li><li>\u27a4 Combined OCPs can be started after beta hCG values return to normal</li><li>\u27a4 Ref: berek and novak, 16 th edition, page 2772</li><li>\u27a4 Ref: berek and novak, 16 th edition, page 2772</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "18900713",
      "audio": ""
    },
    {
      "text": "Gestational trophoblastic neoplasia includes all Except :",
      "options": [
        {
          "label": "A",
          "text": "Choriocarcinoma",
          "correct": false
        },
        {
          "label": "B",
          "text": "Epithelioid trophoblastic tumor (ETT)",
          "correct": false
        },
        {
          "label": "C",
          "text": "Molar pregnancy",
          "correct": true
        },
        {
          "label": "D",
          "text": "Placental site trophoblastic tumor (PSTT)",
          "correct": false
        }
      ],
      "correct_answer": "C. Molar pregnancy",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/16/image.png"
      ],
      "explanation": "<p><strong>Ans. C. Molar pregnancy</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Gestational Trophoblastic  Neoplasias include the following:</li><li>\u27a4 Gestational Trophoblastic  Neoplasias include the following:</li><li>\u27a4 Invasive mole Choriocarcinoma Placental site trophoblatic tumor Epitheloid trophoblastic tumor</li><li>\u27a4 Invasive mole</li><li>\u27a4 Choriocarcinoma</li><li>\u27a4 Placental site trophoblatic tumor</li><li>\u27a4 Epitheloid trophoblastic tumor</li><li>\u27a4 Ref: FIGO cancer report 2021</li><li>\u27a4 Ref: FIGO cancer report 2021</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "89926476",
      "audio": ""
    },
    {
      "text": "A 30-year-old woman underwent suction evacuation for molar pregnancy. Her hCG surveillance is as follows. What is the probable cause: 1 March: 200 7 March: 120 14 March: 900 21 March: 1300 28 March: 1700",
      "options": [
        {
          "label": "A",
          "text": "Gestational trophoblastic neoplasia",
          "correct": true
        },
        {
          "label": "B",
          "text": "Recurrence of molar pregnancy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Relapse of Molar pregnancy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Trophoblastic embolization",
          "correct": false
        }
      ],
      "correct_answer": "A. Gestational trophoblastic neoplasia",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/9_0E8e20u.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Gestational trophoblastic neoplasia</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Gestational Trophoblastic Neoplasia should be suspected in a patient who has had a suction evacuation done followed by plateauing or increasing beta hCG levels OR of beta hCG persists even after 6 months of molar evacuation If the question says that the beta hCG came to zero and again became positive, in such a scenario the 1st thing to think of is pregnancy</li><li>\u27a4 Gestational Trophoblastic Neoplasia should be suspected in a patient who has had a suction evacuation done followed by plateauing or increasing beta hCG levels OR of beta hCG persists even after 6 months of molar evacuation</li><li>\u27a4 Gestational Trophoblastic Neoplasia should be suspected in a patient who has had a suction evacuation done followed by plateauing or increasing beta hCG levels OR of beta hCG persists even after 6 months of molar evacuation</li><li>\u27a4 If the question says that the beta hCG came to zero and again became positive, in such a scenario the 1st thing to think of is pregnancy</li><li>\u27a4 If the question says that the beta hCG came to zero and again became positive, in such a scenario the 1st thing to think of is pregnancy</li><li>\u27a4 Ref: FIGO cnacer report 2021</li><li>\u27a4 Ref: FIGO cnacer report 2021</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "53f186d4",
      "audio": ""
    },
    {
      "text": "GTN can occur after:",
      "options": [
        {
          "label": "A",
          "text": "First trimester Abortion",
          "correct": false
        },
        {
          "label": "B",
          "text": "Molar pregnancy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Term pregnancy",
          "correct": false
        },
        {
          "label": "D",
          "text": "All of the above",
          "correct": true
        }
      ],
      "correct_answer": "D. All of the above",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Gestational Trophoblastic Neoplasia can occur following Molar pregnancy (most commonly; complete mole > partial mole) but can also happen after a term/ preterm pregnancy or after an abortion or an ectopic pregnancy</li><li>\u27a4 Gestational Trophoblastic Neoplasia can occur following Molar pregnancy (most commonly; complete mole > partial mole) but can also happen after a term/ preterm pregnancy or after an abortion or an ectopic pregnancy</li><li>\u27a4 Ref: FIGO cancer report 2021</li><li>\u27a4 Ref: FIGO cancer report 2021</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "154cfb2f",
      "audio": ""
    },
    {
      "text": "A 30-year-old woman has been admitted after 3 increasing weekly hCG values, 2 months after molar evacuation. On examination, cervix, vagina is healthy, uterus is normal size. Her Hb is 10g%, chest X-ray is shown below. What stage of GTN does she have?",
      "options": [
        {
          "label": "A",
          "text": "Stage 1",
          "correct": false
        },
        {
          "label": "B",
          "text": "Stage 2",
          "correct": false
        },
        {
          "label": "C",
          "text": "Stage 3",
          "correct": true
        },
        {
          "label": "D",
          "text": "Stage 4",
          "correct": false
        }
      ],
      "correct_answer": "C. Stage 3",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/10_INAODUi.jpg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/11_5Br7LYv.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/11_5Br7LYv.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Stage 3</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Staging of GTN:</li><li>\u27a4 Staging of GTN:</li><li>\u27a4 Ref: FIGO cancer report 2021, Berek & novak, 16th ed page 2775</li><li>\u27a4 Ref: FIGO cancer report 2021, Berek & novak, 16th ed page 2775</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c7e606e2",
      "audio": ""
    },
    {
      "text": "A 22-year-old woman develops GTN 10 months after abortion. Her beta hCG value is 1,20,000 mIU/mL. The chest X ray shows metastasis. The appropriate treatment for her would be:",
      "options": [
        {
          "label": "A",
          "text": "Actinomycin D injection 5-day regimen",
          "correct": false
        },
        {
          "label": "B",
          "text": "EMA-CO regimen",
          "correct": true
        },
        {
          "label": "C",
          "text": "Methotrexate-folinic acid 8-day regimen",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hysterectomy",
          "correct": false
        }
      ],
      "correct_answer": "B. EMA-CO regimen",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/12_A3tO6F5.jpg"
      ],
      "explanation": "<p><strong>Ans. B. EMA-CO regimen</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The WHO prognostic scoring system in GTN determines the type of chemotherapy If the score is \u2264 6, the patient requires single agent (Methotrexate) chemotherpay. This is given as 4 doses (1mg/Kg) alternating with 4 doses of folinic acid (0.1mg/kg) every 2-3 weeks. If the score > 7 the patient requires multiagent chemotherapy (EMACO). This includes etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine</li><li>\u27a4 The WHO prognostic scoring system in GTN determines the type of chemotherapy</li><li>\u27a4 If the score is \u2264 6, the patient requires single agent (Methotrexate) chemotherpay. This is given as 4 doses (1mg/Kg) alternating with 4 doses of folinic acid (0.1mg/kg) every 2-3 weeks.</li><li>\u27a4 If the score > 7 the patient requires multiagent chemotherapy (EMACO). This includes etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine</li><li>\u27a4 Ref: FIGO cancer report 2021</li><li>\u27a4 Ref: FIGO cancer report 2021</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c6b333b7",
      "audio": ""
    },
    {
      "text": "A 22-year woman develops GTN, 6 months after molar evacuation. On speculum examination, there is a reddish blue nodule in vagina. Her hCG is 24,000mIU/mL. chest XRay is normal. Mhe most appropriate treatment for her is",
      "options": [
        {
          "label": "A",
          "text": "EMA-CO regimen",
          "correct": false
        },
        {
          "label": "B",
          "text": "Embolisation of vaginal nodule",
          "correct": false
        },
        {
          "label": "C",
          "text": "Methotrexate-folinic acid 8 day regimen",
          "correct": true
        },
        {
          "label": "D",
          "text": "Hysterectomy",
          "correct": false
        }
      ],
      "correct_answer": "C. Methotrexate-folinic acid 8 day regimen",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/14.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/15/15.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Methotrexate-folinic acid 8 day regimen</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f000b8cf",
      "audio": ""
    },
    {
      "text": "A 30-year woman with stage 2 GTN is receiving methotrexate-based chemotherapy. How frequently is chemotherapy given and what marker is used to assess response to treatment?",
      "options": [
        {
          "label": "A",
          "text": "2 weekly chemotherapy, response monitored by CA 125",
          "correct": false
        },
        {
          "label": "B",
          "text": "4 weekly chemotherapy, response monitored by CA 125",
          "correct": false
        },
        {
          "label": "C",
          "text": "2 weekly chemotherapy, response monitored by hCG",
          "correct": true
        },
        {
          "label": "D",
          "text": "4 weekly chemotherapy, response monitored by hCG",
          "correct": false
        }
      ],
      "correct_answer": "C. 2 weekly chemotherapy, response monitored by hCG",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. 2 weekly chemotherapy, response monitored by Hcg</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 hCG is used as a marker to diagnose development of GTN, response to chemotherapy and occurance of relapse Both EMACO and Methotrexate are given 2 weekly EMACO is given for high risk GTN Methotrexate is given for low risk GTN</li><li>\u27a4 hCG is used as a marker to diagnose development of GTN, response to chemotherapy and occurance of relapse</li><li>\u27a4 Both EMACO and Methotrexate are given 2 weekly</li><li>\u27a4 EMACO is given for high risk GTN</li><li>\u27a4 Methotrexate is given for low risk GTN</li><li>\u27a4 Ref: FIGO cancer report 2021, Berek and Novak 16th ed Page 2757</li><li>\u27a4 Ref: FIGO cancer report 2021, Berek and Novak 16th ed Page 2757</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8db98df2",
      "audio": ""
    },
    {
      "text": "Regarding chemotherapy in GTN, which of the following is true?",
      "options": [
        {
          "label": "A",
          "text": "Chemotherapy is given for one cycle followed by hCG follow up",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chemotherapy is given for 6 cycles followed by hCG follow up",
          "correct": false
        },
        {
          "label": "C",
          "text": "Chemotherapy is given till hCG undetectable followed by hCG follow up",
          "correct": false
        },
        {
          "label": "D",
          "text": "Chemotherapy is given till hCG undetectable followed by 2-3 consolidation cycles followed by hCG follow up",
          "correct": true
        }
      ],
      "correct_answer": "D. Chemotherapy is given till hCG undetectable followed by 2-3 consolidation cycles followed by hCG follow up",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Chemotherapy is given till hCG undetectable followed by 2-3 consolidation cycles followed by hCG follow up</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Chemotherapy for GTN (for low risk: Mtx-FA and high risk: EMA-CO), it is given 2 weekly till hCG levels are undetectable followed by 2-3 consolidation doses</li><li>\u27a4 Chemotherapy for GTN (for low risk: Mtx-FA and high risk: EMA-CO), it is given 2 weekly till hCG levels are undetectable followed by 2-3 consolidation doses</li><li>\u27a4 Ref: berek & novak 16 edition, page 2785, 2786</li><li>\u27a4 Ref: berek & novak 16 edition, page 2785, 2786</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "21b95af3",
      "audio": ""
    },
    {
      "text": "You have just completed the chemotherapy of GTN patient. How long will you ask her to follow up:",
      "options": [
        {
          "label": "A",
          "text": "3 months",
          "correct": false
        },
        {
          "label": "B",
          "text": "6 months",
          "correct": false
        },
        {
          "label": "C",
          "text": "1 year",
          "correct": true
        },
        {
          "label": "D",
          "text": "2 years",
          "correct": false
        }
      ],
      "correct_answer": "C. 1 year",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. 1 year</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "97f21769",
      "audio": ""
    },
    {
      "text": "A 72y old woman who preseted with a lesion on the vulva underwent a biopsy. This was diagnosed as squamois cell carcinoma which is the most common pathology in vulvar cancers. Which of the following is the second most common vulvar malignancy and accounts for up to 10 percent of all vulvar cancers?",
      "options": [
        {
          "label": "A",
          "text": "Melanoma",
          "correct": true
        },
        {
          "label": "B",
          "text": "Basal cell carcinoma",
          "correct": false
        },
        {
          "label": "C",
          "text": "Squamous cell carcinoma",
          "correct": false
        },
        {
          "label": "D",
          "text": "Bartholin gland adenocarcinoma",
          "correct": false
        }
      ],
      "correct_answer": "A. Melanoma",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Of vulvar tumors, approximately 90 percent are squamous cell carcinoma. Malignant melanoma is the second most common, but rare histologic subtypes may also be encountered.</li><li>\u2022 Of vulvar tumors, approximately 90 percent are squamous cell carcinoma.</li><li>\u2022 Malignant melanoma is the second most common, but rare histologic subtypes may also be encountered.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The etiology of vulval cancer is unclear but certain high risk factors are known to be associated Postmenopausal women; median age about 60 years White race Obesity, Hypertension and Diabetes are known associations More common in nulliparous women Lichen sclerosis HPV (esp high risk types - 16,18) Chronic vulvar irritation Premalignant lesions - vulvar intra-epithelial neoplasia</li><li>\u27a4 The etiology of vulval cancer is unclear but certain high risk factors are known to be associated Postmenopausal women; median age about 60 years White race Obesity, Hypertension and Diabetes are known associations More common in nulliparous women Lichen sclerosis HPV (esp high risk types - 16,18) Chronic vulvar irritation Premalignant lesions - vulvar intra-epithelial neoplasia</li><li>\u27a4 Postmenopausal women; median age about 60 years White race Obesity, Hypertension and Diabetes are known associations More common in nulliparous women Lichen sclerosis HPV (esp high risk types - 16,18) Chronic vulvar irritation Premalignant lesions - vulvar intra-epithelial neoplasia</li><li>\u27a4 Postmenopausal women; median age about 60 years</li><li>\u27a4 White race</li><li>\u27a4 Obesity, Hypertension and Diabetes are known associations</li><li>\u27a4 More common in nulliparous women</li><li>\u27a4 Lichen sclerosis</li><li>\u27a4 HPV (esp high risk types - 16,18)</li><li>\u27a4 Chronic vulvar irritation</li><li>\u27a4 Premalignant lesions - vulvar intra-epithelial neoplasia</li><li>\u27a4 Ref: Page 707, Williams Gynecology 3 rd edition</li><li>\u27a4 Ref: Page 707, Williams Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0426e8a6",
      "audio": ""
    },
    {
      "text": "A 65y postmenopausal woman is dignosed with vulval cancer. She is very surprised as she has been having a very healthy lifestyle. She asks you the risk factors for vulval cancer. Which of the following is not a risk factor for vulval cancer?",
      "options": [
        {
          "label": "A",
          "text": "Lichen planus",
          "correct": true
        },
        {
          "label": "B",
          "text": "Tobacco abuse",
          "correct": false
        },
        {
          "label": "C",
          "text": "Lichen sclerosus",
          "correct": false
        },
        {
          "label": "D",
          "text": "Human papillomavirus",
          "correct": false
        }
      ],
      "correct_answer": "A. Lichen planus",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Risk factors of vulvar cancer are</li><li>\u2022 More common in older age (> 60y) and white race Increased association with obesity, HTN, diabetes and nulliparoty Associated vulvar epithelial disorders: Lichensclerosis, Vulval intra-epithelial neoplasia (VIN), Paget's disease, squamous cell hyperplasia, condyloma acuminata HPV (high risk type 16, 18) Chronic pruritis, chronic irritation of the vulva Vulvar intra-epithepithelial lesion (VIN)</li><li>\u2022 More common in older age (> 60y) and white race</li><li>\u2022 Increased association with obesity, HTN, diabetes and nulliparoty</li><li>\u2022 Associated vulvar epithelial disorders: Lichensclerosis, Vulval intra-epithelial neoplasia (VIN), Paget's disease, squamous cell hyperplasia, condyloma acuminata</li><li>\u2022 HPV (high risk type 16, 18)</li><li>\u2022 Chronic pruritis, chronic irritation of the vulva</li><li>\u2022 Vulvar intra-epithepithelial lesion (VIN)</li><li>\u2022 Lichen planus may affect the skin anywhere on the body. It affects the mucosal surfaces (oral mucosa) and presents with polygenal flat-topped purpuric plaques. The lesion may be erosive and presents more with pain than pruritus. It is NOT commonly associated with vulvar carcinoma</li><li>\u2022 Lichen planus</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Risk factors of vulvar cancer are</li><li>\u27a4 More common in older age (> 60y) and white race Increased association with obesity, HTN, diabetes and nulliparoty Associated vulvar epithelial disorders: Lichensclerosis, Vulval intra-epithelial neoplasia (VIN), Paget's disease, squamous cell hyperplasia, condyloma acuminata HPV (high risk type 16, 18) Chronic pruritis, chronic irritation of the vulva Vulvar intra-epithepithelial lesion (VIN)</li><li>\u27a4 More common in older age (> 60y) and white race</li><li>\u27a4 Increased association with obesity, HTN, diabetes and nulliparoty</li><li>\u27a4 Associated vulvar epithelial disorders: Lichensclerosis, Vulval intra-epithelial neoplasia (VIN), Paget's disease, squamous cell hyperplasia, condyloma acuminata</li><li>\u27a4 HPV (high risk type 16, 18)</li><li>\u27a4 Chronic pruritis, chronic irritation of the vulva</li><li>\u27a4 Vulvar intra-epithepithelial lesion (VIN)</li><li>\u27a4 Ref: Page no 708, Williams Gynecology 3 rd edition</li><li>\u27a4 Ref: Page no 708, Williams Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5b286e54",
      "audio": ""
    },
    {
      "text": "A 62-year-old woman presents for her annual well woman examination and complains of vulvar pruritis. During examination, you note an area of thickened white plaque. What is the most appropriate next step?",
      "options": [
        {
          "label": "A",
          "text": "Biopsy the lesion in your office",
          "correct": true
        },
        {
          "label": "B",
          "text": "Prescribe estrogen cream and follow up in 3 months",
          "correct": false
        },
        {
          "label": "C",
          "text": "Perform a wide local excision in the operating room",
          "correct": false
        },
        {
          "label": "D",
          "text": "Prescribe clobetasol",
          "correct": false
        }
      ],
      "correct_answer": "A. Biopsy the lesion in your office",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/untitled-740.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Biopsy the lesion in your office</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 A post-menopausal woman with a vulvar lesion should be biopsied to rule out vulvar malignancy. Lesions may be raised, ulcerated, pigmented, or warty Importantly, other clinical entities may present similarly and include preinvasive neoplasia (VIN), infection, chronic inflammatory disease, and granulomatous disease, so a biopsy should be done. Multiple biopsies are recommended, from the most suspicious raised or dyspigmented skin are taken Concurrent colposcopic examination of the cervix and vagina and careful evaluation of the perianal area are recommended to diagnose any synchronous lesions or associated neoplasm of the lower genital tract</li><li>\u2022 A post-menopausal woman with a vulvar lesion should be biopsied to rule out vulvar malignancy.</li><li>\u2022 Lesions may be raised, ulcerated, pigmented, or warty</li><li>\u2022 Importantly, other clinical entities may present similarly and include preinvasive neoplasia (VIN), infection, chronic inflammatory disease, and granulomatous disease, so a biopsy should be done.</li><li>\u2022 Multiple biopsies are recommended, from the most suspicious raised or dyspigmented skin are taken</li><li>\u2022 Concurrent colposcopic examination of the cervix and vagina and careful evaluation of the perianal area are recommended to diagnose any synchronous lesions or associated neoplasm of the lower genital tract</li><li>\u2022 Other options</li><li>\u2022 Other options</li><li>\u2022 Clobetasol is a local steroid which may help in several skin conditions but a biopsy is important before prescribing medication Estrogen cream is prescribed for vaginal/ vulvar dryness/ dyspareunia in post menopausal women (Hormone replacement therapy). However the above image does not appear to be a menopausal related vulvar lesion Once biopsy shows a vulvar malignancy, then further evaluation is done to stage the tumor (clinical staging). For microscopic lesions, a wide local excision can be done</li><li>\u2022 Clobetasol is a local steroid which may help in several skin conditions but a biopsy is important before prescribing medication</li><li>\u2022 Estrogen cream is prescribed for vaginal/ vulvar dryness/ dyspareunia in post menopausal women (Hormone replacement therapy). However the above image does not appear to be a menopausal related vulvar lesion</li><li>\u2022 Once biopsy shows a vulvar malignancy, then further evaluation is done to stage the tumor (clinical staging). For microscopic lesions, a wide local excision can be done</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 A post-menopausal woman with a vulvar lesion should be biopsied to rule out vulvar malignancy. Lesions may be raised, ulcerated, pigmented, or warty Importantly, other clinical entities may present similarly and include preinvasive neoplasia (VIN), infection, chronic inflammatory disease, and granulomatous disease, so a biopsy should be done. Multiple biopsies are recommended, from the most suspicious raised or dyspigmented skin are taken Concurrent colposcopic examination of the cervix and vagina and careful evaluation of the perianal area are recommended to diagnose any synchronous lesions or associated neoplasm of the lower genital tract</li><li>\u27a4 A post-menopausal woman with a vulvar lesion should be biopsied to rule out vulvar malignancy.</li><li>\u27a4 Lesions may be raised, ulcerated, pigmented, or warty</li><li>\u27a4 Importantly, other clinical entities may present similarly and include preinvasive neoplasia (VIN), infection, chronic inflammatory disease, and granulomatous disease, so a biopsy should be done.</li><li>\u27a4 Multiple biopsies are recommended, from the most suspicious raised or dyspigmented skin are taken</li><li>\u27a4 Concurrent colposcopic examination of the cervix and vagina and careful evaluation of the perianal area are recommended to diagnose any synchronous lesions or associated neoplasm of the lower genital tract</li><li>\u27a4 Ref: Page no 708, Williams Gynecology 3 rd edition</li><li>\u27a4 Ref: Page no 708, Williams Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "59df5990",
      "audio": ""
    },
    {
      "text": "A 56y woman is diagnosed to have a stage 2 vulvar carcinoma and she undergoes a radical vulvectomy. What is the most important prognostic factor in vulvar cancer?",
      "options": [
        {
          "label": "A",
          "text": "Grade",
          "correct": false
        },
        {
          "label": "B",
          "text": "Tumor size",
          "correct": false
        },
        {
          "label": "C",
          "text": "Depth of invasion",
          "correct": false
        },
        {
          "label": "D",
          "text": "Lymph node metastasis",
          "correct": true
        }
      ],
      "correct_answer": "D. Lymph node metastasis",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Prognostic factors in vulval ca are:</li><li>\u2022 Lymph node metastases (This is the single most important vulvar cancer predictor, since inguinal node metastasis reduces long-term survival rates by 50 percent) FIGO Stage Lesion size Depth of invasion Resected-margin status and Lymphatic vascular space involvement (LVSI)</li><li>\u2022 Lymph node metastases (This is the single most important vulvar cancer predictor, since inguinal node metastasis reduces long-term survival rates by 50 percent)</li><li>\u2022 (This is the single most important vulvar cancer predictor, since inguinal node metastasis reduces long-term survival rates by 50 percent)</li><li>\u2022 FIGO Stage</li><li>\u2022 Lesion size</li><li>\u2022 Depth of invasion</li><li>\u2022 Resected-margin status and</li><li>\u2022 Lymphatic vascular space involvement (LVSI)</li><li>\u2022 Ref: Page 710, Williams Gyn, 3 rd edition</li><li>\u2022 Ref: Page 710, Williams Gyn, 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "60ecf011",
      "audio": ""
    },
    {
      "text": "What technique can decrease the risk of lymphedema?",
      "options": [
        {
          "label": "A",
          "text": "Spare the saphenous vein",
          "correct": true
        },
        {
          "label": "B",
          "text": "Use compression stockings",
          "correct": false
        },
        {
          "label": "C",
          "text": "Transpose the sartorius muscle",
          "correct": false
        },
        {
          "label": "D",
          "text": "Avoid drain placement at the time of inguinofemoral dissection",
          "correct": false
        }
      ],
      "correct_answer": "A. Spare the saphenous vein",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Chronic lymphedema is a frequent complication o inguinal lymphadenectomy. Preservation o the saphenous vein has been shown to reduce the incidence Regardless, this condition is typically much more problematic with the addition of groin radiation Supportive management is meant to minimize the edema and prevent symptomatic progression. Foot elevation, compression stockings, and, on occasion, diuretic therapy may be helpful</li><li>\u2022 Chronic lymphedema is a frequent complication o inguinal lymphadenectomy.</li><li>\u2022 Preservation o the saphenous vein has been shown to reduce the incidence</li><li>\u2022 Regardless, this condition is typically much more problematic with the addition of groin radiation</li><li>\u2022 Supportive management is meant to minimize the edema and prevent symptomatic progression.</li><li>\u2022 Foot elevation, compression stockings, and, on occasion, diuretic therapy may be helpful</li><li>\u2022 Ref: !245, Williams Gynecology 3 rd edition</li><li>\u2022 Ref: !245, Williams Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a2f884b0",
      "audio": ""
    },
    {
      "text": "Which of the following is INCORRECT regarding the tumor shown here involving the outer surface of the right labia minora?",
      "options": [
        {
          "label": "A",
          "text": "It is typically a disease of the elderly",
          "correct": false
        },
        {
          "label": "B",
          "text": "It commonly arises from the labia minora and clitoris",
          "correct": false
        },
        {
          "label": "C",
          "text": "Differential diagnoses include seborrheic keratosis and dysplastic nevi",
          "correct": false
        },
        {
          "label": "D",
          "text": "It is more common in African American women than Caucasian women",
          "correct": true
        }
      ],
      "correct_answer": "D. It is more common in African American women than Caucasian women",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/untitled-743.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 This is a vulvar carcinoma which appears like a melanoma as It is pigmented Let us discuss all the options: Option A: It is typically a disease of the elderly: This is correct. Vulvla melanoma disproprtionately affects the elderly Option B: It commonly arises from the labia minora and clitoris. This is also correct. The common sites are the laboa minora, majora and clitoris Option C: Differential diagnoses include seborrheic keratosis and dysplastic nevi. This is also correct . Diferential diagnosis include pigmented lesions like include lentigo simplex, vulvar melanosis, acanthosis nigricans, seborrheic keratosis, and nevi Option D. It is more common in African American women than Caucasian women: This is incorrect. It is more common amongst whites.</li><li>\u2022 This is a vulvar carcinoma which appears like a melanoma as It is pigmented</li><li>\u2022 Let us discuss all the options: Option A: It is typically a disease of the elderly: This is correct. Vulvla melanoma disproprtionately affects the elderly Option B: It commonly arises from the labia minora and clitoris. This is also correct. The common sites are the laboa minora, majora and clitoris Option C: Differential diagnoses include seborrheic keratosis and dysplastic nevi. This is also correct . Diferential diagnosis include pigmented lesions like include lentigo simplex, vulvar melanosis, acanthosis nigricans, seborrheic keratosis, and nevi Option D. It is more common in African American women than Caucasian women: This is incorrect. It is more common amongst whites.</li><li>\u2022 Option A: It is typically a disease of the elderly: This is correct. Vulvla melanoma disproprtionately affects the elderly Option B: It commonly arises from the labia minora and clitoris. This is also correct. The common sites are the laboa minora, majora and clitoris Option C: Differential diagnoses include seborrheic keratosis and dysplastic nevi. This is also correct . Diferential diagnosis include pigmented lesions like include lentigo simplex, vulvar melanosis, acanthosis nigricans, seborrheic keratosis, and nevi Option D. It is more common in African American women than Caucasian women: This is incorrect. It is more common amongst whites.</li><li>\u2022 Option A: It is typically a disease of the elderly: This is correct. Vulvla melanoma disproprtionately affects the elderly</li><li>\u2022 Option A: It is typically a disease of the elderly:</li><li>\u2022 Option B: It commonly arises from the labia minora and clitoris. This is also correct. The common sites are the laboa minora, majora and clitoris</li><li>\u2022 Option B: It commonly arises from the labia minora and clitoris.</li><li>\u2022 Option C: Differential diagnoses include seborrheic keratosis and dysplastic nevi. This is also correct . Diferential diagnosis include pigmented lesions like include lentigo simplex, vulvar melanosis, acanthosis nigricans, seborrheic keratosis, and nevi</li><li>\u2022 Option C: Differential diagnoses include seborrheic keratosis and dysplastic nevi.</li><li>\u2022 .</li><li>\u2022 Option D. It is more common in African American women than Caucasian women: This is incorrect. It is more common amongst whites.</li><li>\u2022 Option D. It is more common in African American women than Caucasian women:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Vulval melanoma is the second most common vulvar cancer and accounts or 10 percent of all vulvar malignancies. Vulvar melanoma disproportionately affects the elderly and develops more commonly among whites than other races. Vulvar melanoma has an overall poor prognosis, and 5-year survival rates range from 8 to 55 percent Malignant vulvar melanomas most commonly arise from the labia minora, labia majora, or clitoris Some benign pigmented lesions can also be found here and include lentigo simplex, vulvar melanosis, acanthosis nigricans, seborrheic keratosis, and nevi Tissue sampling is mandatory for diagnosis</li><li>\u27a4 Vulval melanoma is the second most common vulvar cancer and accounts or 10 percent of all vulvar malignancies.</li><li>\u27a4 Vulvar melanoma disproportionately affects the elderly and develops more commonly among whites than other races.</li><li>\u27a4 Vulvar melanoma has an overall poor prognosis, and 5-year survival rates range from 8 to 55 percent</li><li>\u27a4 Malignant vulvar melanomas most commonly arise from the labia minora, labia majora, or clitoris</li><li>\u27a4 Some benign pigmented lesions can also be found here and include lentigo simplex, vulvar melanosis, acanthosis nigricans, seborrheic keratosis, and nevi</li><li>\u27a4 Tissue sampling is mandatory for diagnosis</li><li>\u27a4 Ref: Page 716, Williams Gynecology 3 rd edition</li><li>\u27a4 Ref: Page 716, Williams Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ba8bcfe4",
      "audio": ""
    },
    {
      "text": "What is the maximum depth of invasion to be considered minimally invasive vulvar cancer?",
      "options": [
        {
          "label": "A",
          "text": "1 mm",
          "correct": true
        },
        {
          "label": "B",
          "text": "3 mm",
          "correct": false
        },
        {
          "label": "C",
          "text": "5 mm",
          "correct": false
        },
        {
          "label": "D",
          "text": "7 mm",
          "correct": false
        }
      ],
      "correct_answer": "A. 1 mm",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/02/screenshot-2023-09-02-151851_xfx5lfx.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/untitled-742.jpg"
      ],
      "explanation": "<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Page no 682, Williams Gynecology, 3rd edition</li><li>\u27a4 Ref: Page no 682, Williams Gynecology, 3rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c835d834",
      "audio": ""
    },
    {
      "text": "The internal pudendal artery is a branch of which artery?",
      "options": [
        {
          "label": "A",
          "text": "Femoral artery",
          "correct": false
        },
        {
          "label": "B",
          "text": "External iliac artery",
          "correct": false
        },
        {
          "label": "C",
          "text": "Internal iliac artery",
          "correct": true
        },
        {
          "label": "D",
          "text": "Superficial pudendal artery",
          "correct": false
        }
      ],
      "correct_answer": "C. Internal iliac artery",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/untitled-739.jpg"
      ],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 The internal pudendal artery is a branch of the internal iliac artery</li><li>\u2022 The internal pudendal artery is a branch of the internal iliac artery</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Page no 705, Williams Gynecology 3 rd edition</li><li>\u27a4 Ref: Page no 705, Williams Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "04b82493",
      "audio": ""
    },
    {
      "text": "A gynecological oncologist performs a radical vulvectomy and bilateral inguinofemoral lymph node dissection for a 3-cm invasive squamous cell carcinoma of the vulva involving the lower third of the vagina. The final histo-pathologic analysis of the specimen reveals margins and lymph nodes that are negative for cancer. Based on these findings, which International Federation of Gynecology and Obstetrics (FIGO) stage is she assigned?",
      "options": [
        {
          "label": "A",
          "text": "I",
          "correct": false
        },
        {
          "label": "B",
          "text": "II",
          "correct": true
        },
        {
          "label": "C",
          "text": "III",
          "correct": false
        },
        {
          "label": "D",
          "text": "IVA",
          "correct": false
        }
      ],
      "correct_answer": "B. II",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/02/screenshot-2023-09-02-151851.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/untitled-742_VdLVY3u.jpg"
      ],
      "explanation": "<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6ccf50c3",
      "audio": ""
    },
    {
      "text": "What is the most appropriate treatment for a 55-yearold patient with a 4-cm squamous cell carcinoma of the vulva involving the urethral meatus and a medical history significant for systemic lupus erythematosus?",
      "options": [
        {
          "label": "A",
          "text": "Chemoradiation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pelvic exenteration",
          "correct": false
        },
        {
          "label": "C",
          "text": "Chemoradiation followed by radical vulvectomy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Radical vulvectomy with bilateral inguinofemoral lymph node dissection",
          "correct": true
        }
      ],
      "correct_answer": "D. Radical vulvectomy with bilateral inguinofemoral lymph node dissection",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 This patient is stage 3 vulvar cancer. The management of stage 3 vulcar cancer is modified radical vulvectomy with b/l inguinofemoral lymphadenectomy</li><li>\u2022 This patient is stage 3 vulvar cancer.</li><li>\u2022 The management of stage 3 vulcar cancer is modified radical vulvectomy with b/l inguinofemoral lymphadenectomy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Treatment of vulval cancer</li><li>\u27a4 Treatment of vulval cancer</li><li>\u27a4 For both stage I and stage 2 disease: radical local excision and sentinel node dissection is indicated, and groin dissection is reserved for those with metastasis to the sentinel node(s). For stage 3: Modified radical or radical vulvectomy with inguinal and femoral lymphadenectomy is the standard therapy. Nodal involvement is a key determinant of survival. Radiation therapy is given to patients with large primary lesions and narrow margins. Stage 4: Radical vulvectomy and pelvic exenteration may be indicated for patients with stage IVA vulvar cancer. Surgery followed by radiation therapy may be done for large, resected lesions with narrow margins. This patient has a stage 2 or 3 vulvar carcinoma (As lymph nodal status is not mentioned); and the best treatment option is a radical vulvectomy with b/l LN inguino-femoral dissection Her medical history wil not change her treatment</li><li>\u27a4 For both stage I and stage 2 disease: radical local excision and sentinel node dissection is indicated, and groin dissection is reserved for those with metastasis to the sentinel node(s).</li><li>\u27a4 stage I and stage 2</li><li>\u27a4 For stage 3: Modified radical or radical vulvectomy with inguinal and femoral lymphadenectomy is the standard therapy. Nodal involvement is a key determinant of survival. Radiation therapy is given to patients with large primary lesions and narrow margins.</li><li>\u27a4 For stage 3:</li><li>\u27a4 Modified radical or radical vulvectomy with inguinal and femoral lymphadenectomy is the standard therapy. Nodal involvement is a key determinant of survival. Radiation therapy is given to patients with large primary lesions and narrow margins.</li><li>\u27a4 Modified radical or radical vulvectomy with inguinal and femoral lymphadenectomy is the standard therapy.</li><li>\u27a4 Nodal involvement is a key determinant of survival. Radiation therapy is given to patients with large primary lesions and narrow margins.</li><li>\u27a4 Stage 4: Radical vulvectomy and pelvic exenteration may be indicated for patients with stage IVA vulvar cancer. Surgery followed by radiation therapy may be done for large, resected lesions with narrow margins.</li><li>\u27a4 Stage 4:</li><li>\u27a4 Radical vulvectomy and pelvic exenteration may be indicated for patients with stage IVA vulvar cancer. Surgery followed by radiation therapy may be done for large, resected lesions with narrow margins.</li><li>\u27a4 Radical vulvectomy and pelvic exenteration may be indicated for patients with stage IVA vulvar cancer.</li><li>\u27a4 Surgery followed by radiation therapy may be done for large, resected lesions with narrow margins.</li><li>\u27a4 This patient has a stage 2 or 3 vulvar carcinoma (As lymph nodal status is not mentioned); and the best treatment option is a radical vulvectomy with b/l LN inguino-femoral dissection</li><li>\u27a4 Her medical history wil not change her treatment</li><li>\u27a4 Ref: Page no 714, Williams Gynecology 3 rd edition</li><li>\u27a4 Ref: Page no 714, Williams Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8dfeff4c",
      "audio": ""
    },
    {
      "text": "What is the most appropriate treatment for a 3-cm basal cell carcinoma of the right vulva, 2cm from the midline?",
      "options": [
        {
          "label": "A",
          "text": "Wide local excision with a 1-cm margin",
          "correct": true
        },
        {
          "label": "B",
          "text": "Wide local excision with a 2-cm margin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Radical vulvectomy with right inguinofemoral lymph node dissection",
          "correct": false
        },
        {
          "label": "D",
          "text": "Radical vulvectomy with bilateral inguinofemoral lymph node dissection",
          "correct": false
        }
      ],
      "correct_answer": "A. Wide local excision with a 1-cm margin",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 This is a basal cell carcinoma Basal cell carcinoma (BCC) of the vulva accounts or < 2 percent of all vulvar cancers and is most commonly found in elderly women Lesions typically arise on the labia majora, are characterized by poor pigmentation and pruritus, and often mimic eczema, psoriasis, or intertrigo. . Basal cell carcinoma is removed by radical partial vulvectomy using a minimum surgical margin of 1 cm. Lymphatic or distant spread is rare, but inguino femoral lymphadenectomy or Sentniel lymoh node biopsy is considered on clinically suspicious nodes.</li><li>\u2022 This is a basal cell carcinoma</li><li>\u2022 Basal cell carcinoma (BCC) of the vulva accounts or < 2 percent of all vulvar cancers and is most commonly found in elderly women</li><li>\u2022 Lesions typically arise on the labia majora, are characterized by poor pigmentation and pruritus, and often mimic eczema, psoriasis, or intertrigo. .</li><li>\u2022 Basal cell carcinoma is removed by radical partial vulvectomy using a minimum surgical margin of 1 cm.</li><li>\u2022 Lymphatic or distant spread is rare, but inguino femoral lymphadenectomy or Sentniel lymoh node biopsy is considered on clinically suspicious nodes.</li><li>\u2022 Ref: Page 717, Williams Gynecology 3 rd edition</li><li>\u2022 Ref: Page 717, Williams Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "daccb096",
      "audio": ""
    },
    {
      "text": "What percentage of vulvar cancers is positive for human papillomavirus (HPV)?",
      "options": [
        {
          "label": "A",
          "text": "0",
          "correct": false
        },
        {
          "label": "B",
          "text": "5",
          "correct": false
        },
        {
          "label": "C",
          "text": "30",
          "correct": false
        },
        {
          "label": "D",
          "text": "50",
          "correct": true
        }
      ],
      "correct_answer": "D. 50",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. 50</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Risk factors of vulvar cancer are</li><li>\u2022 More common in older age (> 60y) and white race Increased association with obesity, HTN, diabetes and nulliparoty Associated vulvar epithelial disorders: Lichensclerosis, Vulval intra-epithelial neoplasia (VIN), Paget's disease, squamous cell hyperplasia, condyloma acuminata HPV (high risk type 16, 18): in 50% of cases. A history of HPV genital warts have a 35-fold increased risk for developing vulvar cancer compared with women who have never developed these lesions. Chronic pruritis, chronic irritation of the vulva Vulvar intra-epithepithelial lesion (VIN)</li><li>\u2022 More common in older age (> 60y) and white race</li><li>\u2022 Increased association with obesity, HTN, diabetes and nulliparoty</li><li>\u2022 Associated vulvar epithelial disorders: Lichensclerosis, Vulval intra-epithelial neoplasia (VIN), Paget's disease, squamous cell hyperplasia, condyloma acuminata</li><li>\u2022 HPV (high risk type 16, 18): in 50% of cases. A history of HPV genital warts have a 35-fold increased risk for developing vulvar cancer compared with women who have never developed these lesions.</li><li>\u2022 Chronic pruritis, chronic irritation of the vulva</li><li>\u2022 Vulvar intra-epithepithelial lesion (VIN)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 HPV (high risk type 16, 18): is seen in 50% of cases of vulvar cancer.  A history of HPV genital warts have a 35-fold increased risk for developing vulvar cancer compared with women who have never developed these lesions.</li><li>\u27a4 Ref: Page no 708, Williams Gynecology 3 rd edition</li><li>\u27a4 Ref: Page no 708, Williams Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4710277f",
      "audio": ""
    },
    {
      "text": "A 64y lady undergoes radical vulvectomy with inguinofermoral lymoh node dissection for vulvar cancer. What is the most common complication of an inguinofemoral lymph node dissection?",
      "options": [
        {
          "label": "A",
          "text": "Lymphocele",
          "correct": false
        },
        {
          "label": "B",
          "text": "Lymphedema",
          "correct": true
        },
        {
          "label": "C",
          "text": "Groin infection",
          "correct": false
        },
        {
          "label": "D",
          "text": "Wound dehiscence",
          "correct": false
        }
      ],
      "correct_answer": "B. Lymphedema",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Following inguino-femoral lymph node dissection, the following complications are noted:</li><li>\u2022 Lymphedema: Amongst all complications, the most common complication of inguino-femoral LN dissection is a lymohedema Lymphocele Groin infection Groin necrosis Groin seperation</li><li>\u2022 Lymphedema: Amongst all complications, the most common complication of inguino-femoral LN dissection is a lymohedema</li><li>\u2022 Lymphocele</li><li>\u2022 Groin infection</li><li>\u2022 Groin necrosis</li><li>\u2022 Groin seperation</li><li>\u2022 Ref: Page no 715, Williams Gynecology, 3 rd edition</li><li>\u2022 Ref: Page no 715, Williams Gynecology, 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9b0affa7",
      "audio": ""
    },
    {
      "text": "You perform a radical vulvectomy with bilateral inguinofemoral lymphadenectomy on a woman with a 4-cm squamous cell carcinoma tumor of the vulva. Margins are negative for cancer, but there are three positive lymph nodes. What is the most appropriate treatment?",
      "options": [
        {
          "label": "A",
          "text": "Radiation alone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chemoradiation",
          "correct": true
        },
        {
          "label": "C",
          "text": "Close observation",
          "correct": false
        },
        {
          "label": "D",
          "text": "Pelvic lymph node dissection",
          "correct": false
        }
      ],
      "correct_answer": "B. Chemoradiation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 This is a stage III vulvar cancers (Tumor of any size with or without extension to adjacent perineal structures (lower 1/3rd urethera, lower 1/3rd vagina, anus) with positive inguino-femoral nodes. Women with stage III vulvar cancer are treated with surger followed by adjuvant radiation therapy directed to both groins and the pelvis. The addition of platinum-based chemotherapy concurrent with radiation therapy is also now given, and hence the best answer here is chemo-radiation</li><li>\u2022 This is a stage III vulvar cancers (Tumor of any size with or without extension to adjacent perineal structures (lower 1/3rd urethera, lower 1/3rd vagina, anus) with positive inguino-femoral nodes.</li><li>\u2022 Women with stage III vulvar cancer are treated with surger followed by adjuvant radiation therapy directed to both groins and the pelvis.</li><li>\u2022 The addition of platinum-based chemotherapy concurrent with radiation therapy is also now given, and hence the best answer here is chemo-radiation</li><li>\u2022 Ref: Page 714, Williams Gyn, 3 rd edition</li><li>\u2022 Ref: Page 714, Williams Gyn, 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4de8051e",
      "audio": ""
    },
    {
      "text": "A 54-year-old woman presents with the persistent vulvar mass seen in the picture below and complaints of dyspareunia. What is the most appropriate management?",
      "options": [
        {
          "label": "A",
          "text": "Antibiotics",
          "correct": false
        },
        {
          "label": "B",
          "text": "Incision and drainage with marsupialization",
          "correct": false
        },
        {
          "label": "C",
          "text": "Incision and drainage with excision of the gland",
          "correct": true
        },
        {
          "label": "D",
          "text": "Incision and drainage",
          "correct": false
        }
      ],
      "correct_answer": "C. Incision and drainage with excision of the gland",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/14/untitled-744.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 This is a Bartholin gland cyst Bartholin gland enlargement in a woman older than 40 years and recurrent cysts or abscesses warrants a biopsy or excision as there could be an underlying adenocarcinoma In a young woman, the treatment of choice of a Bartholin duct cyst is marsupialiation</li><li>\u2022 This is a Bartholin gland cyst</li><li>\u2022 Bartholin gland enlargement in a woman older than 40 years and recurrent cysts or abscesses warrants a biopsy or excision as there could be an underlying adenocarcinoma</li><li>\u2022 In a young woman, the treatment of choice of a Bartholin duct cyst is marsupialiation</li><li>\u2022 Ref: Page no 718, Williams Gynecology 3 rd edition</li><li>\u2022 Ref: Page no 718, Williams Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "443b0f8f",
      "audio": ""
    },
    {
      "text": "A 52-year-old woman presents with a suspicious vulvar lesion. A biopsy confirms the presence of squamous cell carcinoma of the vulva. Clinical exam and imaging show no evidence of metastases. Her healthcare team decided to perform a sentinel lymph node biopsy (SLNB) to assess lymph node involvement. Which of the following is a true statement?",
      "options": [
        {
          "label": "A",
          "text": "SLNB is usually not recommended in vulvar carcinoma as lymphatic spread is rare",
          "correct": false
        },
        {
          "label": "B",
          "text": "SLNB is primarily used for staging and does not influence the management of vulvar carcinoma",
          "correct": false
        },
        {
          "label": "C",
          "text": "SLNB is used to identify the 1 st lymph node(s) that cancer cells are likely to spread to and can guide lymph node dissection if positive",
          "correct": true
        },
        {
          "label": "D",
          "text": "SLNB is the sole definitive treatment for vulvar carcinoma and eliminates the need for further surgery or radiotherapy",
          "correct": false
        }
      ],
      "correct_answer": "C. SLNB is used to identify the 1 st lymph node(s) that cancer cells are likely to spread to and can guide lymph node dissection if positive",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Role of Sentinel LN Biopsy in Vulvar Carcinoma</li><li>\u2022 Role of Sentinel LN Biopsy in Vulvar Carcinoma</li><li>\u2022 Reduces the requirement of LN dissection in vulvar carcinoma The main route of spread of vulvar carcinoma is lymphatic spread Done by lymphoscintigraphy with Tc99 labelled isosulfan blue dye/ indocyanine fluorescent green Groin incision made 10 mins later Colored node is excised and examined If negative: No lymphadenectomy needs to be done If positive: B/l inguinofemoral lymphadenectomy is done</li><li>\u2022 Reduces the requirement of LN dissection in vulvar carcinoma</li><li>\u2022 The main route of spread of vulvar carcinoma is lymphatic spread</li><li>\u2022 Done by lymphoscintigraphy with Tc99 labelled isosulfan blue dye/ indocyanine fluorescent green</li><li>\u2022 Groin incision made 10 mins later</li><li>\u2022 Colored node is excised and examined</li><li>\u2022 If negative: No lymphadenectomy needs to be done</li><li>\u2022 If positive: B/l inguinofemoral lymphadenectomy is done</li><li>\u2022 Other Options:</li><li>\u2022 Other Options:</li><li>\u2022 Option A. SLNB is usually not recommended in vulvar carcinoma as lymphatic spread is rare: This is a wrong statement as lymphatic spread is the most common route of spread of vulvar cancers Option B. SLNB is primarily used for staging and does not influence the management of vulvar carcinoma: This is a wrong statement as SLNB is mainly done to reduce the risk of LN dissection thereby preventing complications Option D: SLNB is the sole definitive treatment for vulvar carcinoma and eliminates the need for further surgery or radiotherapy: This is a wrong statement as SLNB is not the mainstay of treatment.</li><li>\u2022 Option A. SLNB is usually not recommended in vulvar carcinoma as lymphatic spread is rare: This is a wrong statement as lymphatic spread is the most common route of spread of vulvar cancers</li><li>\u2022 Option A.</li><li>\u2022 Option B. SLNB is primarily used for staging and does not influence the management of vulvar carcinoma: This is a wrong statement as SLNB is mainly done to reduce the risk of LN dissection thereby preventing complications</li><li>\u2022 Option B.</li><li>\u2022 Option D: SLNB is the sole definitive treatment for vulvar carcinoma and eliminates the need for further surgery or radiotherapy: This is a wrong statement as SLNB is not the mainstay of treatment.</li><li>\u2022 Option D:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Role of Sentinel LN Biopsy in Vulvar Carcinoma</li><li>\u27a4 Role of Sentinel LN Biopsy in Vulvar Carcinoma</li><li>\u27a4 Reduces the requirement of LN dissection in vulvar carcinoma The main route of spread of vulvar carcinoma is lymphatic spread</li><li>\u27a4 Reduces the requirement of LN dissection in vulvar carcinoma</li><li>\u27a4 The main route of spread of vulvar carcinoma is lymphatic spread</li><li>\u27a4 Ref: page 686, Williams Gynecology, 3 rd edition</li><li>\u27a4 Ref: page 686, Williams Gynecology, 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8333a38f",
      "audio": ""
    },
    {
      "text": "A 55 years old P5L5 presented to OPD with postcoital bleeding and vaginal discharge. On examination, there is a 3 x 3cm growth involving the entire cervix. The growth does not seenm to extend to the vagina and the parametrium is free. Which of the following investigations can be used for staging of cancer cervix:",
      "options": [
        {
          "label": "A",
          "text": "Chest X Ray",
          "correct": false
        },
        {
          "label": "B",
          "text": "CT scan",
          "correct": false
        },
        {
          "label": "C",
          "text": "MRI",
          "correct": false
        },
        {
          "label": "D",
          "text": "All of the above",
          "correct": true
        }
      ],
      "correct_answer": "D. All of the above",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. All of the above:</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Cervical cancer is primarily a clinical staging but F IGO 2018 staging permits the use of any of the imaging modalities according to available resources, i.e. ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET) , to provide additional information on tumor size, nodal status, and local or systemic spread.</li><li>\u27a4 Cervical cancer is primarily a clinical staging but F IGO 2018 staging permits the use of any of the imaging modalities according to available resources, i.e. ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET) , to provide additional information on tumor size, nodal status, and local or systemic spread.</li><li>\u27a4 i.e. ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET)</li><li>\u27a4 Ref  : FIGO cancer report 2021</li><li>\u27a4 Ref  : FIGO cancer report 2021</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d5bd3a6b",
      "audio": ""
    },
    {
      "text": "A 57 year old woman presents to OPD with complaint of discharge per vagina. There is a 3*3 cm visible growth on the cervix. Vagina and parametrium are uninvolved. The stage of the disease is:",
      "options": [
        {
          "label": "A",
          "text": "Stage IB1",
          "correct": false
        },
        {
          "label": "B",
          "text": "Stage IB2",
          "correct": true
        },
        {
          "label": "C",
          "text": "Stage IB3",
          "correct": false
        },
        {
          "label": "D",
          "text": "Stage IIA1",
          "correct": false
        }
      ],
      "correct_answer": "B. Stage IB2",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/17/whatsapp-image-2023-06-12-at-1901123.jpg"
      ],
      "explanation": "<p><strong>Ans. B. Stage IB2</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Staging of cervical cancr is essential to learn as given in the table above</li><li>\u27a4 Staging of cervical cancr is essential to learn as given in the table above</li><li>\u27a4 Ref :  FIGO cancer report 2021</li><li>\u27a4 Ref :  FIGO cancer report 2021</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "de9c6335",
      "audio": ""
    },
    {
      "text": "Identify the instrument:",
      "options": [
        {
          "label": "A",
          "text": "Allis tissue holding forcep",
          "correct": false
        },
        {
          "label": "B",
          "text": "Babcock forceps",
          "correct": false
        },
        {
          "label": "C",
          "text": "Cervical punch biopsy forcep",
          "correct": true
        },
        {
          "label": "D",
          "text": "Pipelle\u2019s endometrial biopsy forcep",
          "correct": false
        }
      ],
      "correct_answer": "C. Cervical punch biopsy forcep",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/17/whatsapp-image-2023-06-12-at-1901124.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Cervical punch biopsy forceps</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Any growth on the cervix should be biopsied using a punch biopsy forceps</li><li>\u27a4 Any growth on the cervix should be biopsied using a punch biopsy forceps</li><li>\u27a4 Ref: Page no 605, DC Dutta's Textbook of Gynecology, 6th edition</li><li>\u27a4 Ref: Page no 605, DC Dutta's Textbook of Gynecology, 6th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "636ab3e0",
      "audio": ""
    },
    {
      "text": "A 56 year old parous lady visits the gynecology OPD with complaint of vaginal bleeding. On examination, there is a 3 x 3cm growth involving cervix and upper part of vagina. Which of the following imaging would be most useful in staging and management of the disease?",
      "options": [
        {
          "label": "A",
          "text": "Ultrasound",
          "correct": false
        },
        {
          "label": "B",
          "text": "CT scan",
          "correct": false
        },
        {
          "label": "C",
          "text": "MRI",
          "correct": true
        },
        {
          "label": "D",
          "text": "Imaging modalities should not be used for staging or management",
          "correct": false
        }
      ],
      "correct_answer": "C. MRI",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. MRI</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cervical cancer is primarily a clinical staging but FIGO 2018 staging permits the use of any of the imaging modalities according to available resources, i.e. ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET) , to provide additional information on tumor size, nodal status, and local or systemic spread.</li><li>\u27a4 i.e. ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET)</li><li>\u27a4 Ref : Berek and novak 16 th edition, 2457</li><li>\u27a4 Ref :</li><li>\u27a4 Berek and novak 16 th edition, 2457</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ac3b60d3",
      "audio": ""
    },
    {
      "text": "A 50 years lady presents with foul smelling vaginal discharge since a few months. She is post-menopausal since 2 years. On examination, there is a 3.5 x 3cm growth, involving the upper part of vagina and bilateral parametrium appears free. An MRI done, shows growth involving upper vagina and parametrium, but not upto the lateral pelvic wall. The stage of the disease is:",
      "options": [
        {
          "label": "A",
          "text": "Stage IIA1",
          "correct": false
        },
        {
          "label": "B",
          "text": "Stage IIA2",
          "correct": false
        },
        {
          "label": "C",
          "text": "Stage IIBr",
          "correct": true
        },
        {
          "label": "D",
          "text": "Stage IIIB2r",
          "correct": false
        }
      ],
      "correct_answer": "C. Stage IIBr",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/17/whatsapp-image-2023-06-12-at-1901123.jpg"
      ],
      "explanation": "<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f174dc1d",
      "audio": ""
    },
    {
      "text": "Which of the following is TRUE regarding staging of cervical cancer?",
      "options": [
        {
          "label": "A",
          "text": "Stage IA1 : microscopically detected carcinoma \u2264 5 mm depth and \u2264 7mm extension",
          "correct": false
        },
        {
          "label": "B",
          "text": "Stage IB1 : Cancer confined to cervix, lesion \u2264 4 cm in greatest dimension",
          "correct": false
        },
        {
          "label": "C",
          "text": "Stage IB2: Cancer confined to cervix, lesion > 4 cm in greatest dimension",
          "correct": false
        },
        {
          "label": "D",
          "text": "Stage IIA: Cervical carcinoma involving upper 2/3 rd of vagina",
          "correct": true
        }
      ],
      "correct_answer": "D. Stage IIA: Cervical carcinoma involving upper 2/3 rd of vagina",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/17/whatsapp-image-2023-06-12-at-1901123.jpg"
      ],
      "explanation": "<p><strong>Ans. D. Stage IIA: Cervical carcinoma involving upper 2/3rdof vagina</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Staging of cervical cancer is primarily a clinical staging and it is important to know this staging as shown in the table above</li><li>\u27a4 Ref: Berek and novak 16 th edition, 2455</li><li>\u27a4 Ref: Berek and novak 16 th edition, 2455</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "03068e96",
      "audio": ""
    },
    {
      "text": "Mrs Mala, a 40-year-old P2L2, underwent radical hysterectomy for cancer cervix. A dvantages of surgery over radiotherapy in treatment of cervical cancer are all EXCEPT:",
      "options": [
        {
          "label": "A",
          "text": "Better disease eradication",
          "correct": true
        },
        {
          "label": "B",
          "text": "Conservation of ovaries can be tried",
          "correct": false
        },
        {
          "label": "C",
          "text": "Less bowel, bladder problems",
          "correct": false
        },
        {
          "label": "D",
          "text": "Less sexual dysfunction",
          "correct": false
        }
      ],
      "correct_answer": "A. Better disease eradication",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/17/whatsapp-image-2023-06-12-at-1901125.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/17/whatsapp-image-2023-06-12-at-1901125.jpg"
      ],
      "explanation": "<p><strong>Ans. A (better disease eradication)</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Berek and novak, 16 th edition 2470, 2487</li><li>\u27a4 Ref: Berek and novak, 16 th edition 2470, 2487</li><li>\u27a4 DC Dutta's Textbook of Gynecology, 6th edition, page 348</li><li>\u27a4 DC Dutta's Textbook of Gynecology, 6th edition, page 348</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "19ea828e",
      "audio": ""
    },
    {
      "text": "Mrs A, 56 year old woman, underwent Wertheim\u2019s hysterectomy for cancer cervix. What type of hysterectomy is this :",
      "options": [
        {
          "label": "A",
          "text": "Type 1 hysterectomy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Type 2 hysterectomy",
          "correct": true
        },
        {
          "label": "C",
          "text": "Type 3 hysterectomy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Type 4 hysterectomy",
          "correct": false
        }
      ],
      "correct_answer": "B. Type 2 hysterectomy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Type 2 hysterectomy</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Types of hysterectomies:</li><li>\u27a4 A Type 1 hysterectomy is also called an e xtra-fasical hysterectomy and is done in non malignant or pre-malignant conditions. It involves ligation of the uterine artery, uterosacral and cardinal ligaments at the proximal part No vaginal cuff is removed A Type 2 hysterectomy (Wertheim hysterectomy) Uterine arteries divided just medial to the ureter Uterosacral ligaments divided midway Cardinal ligaments divided midway 2/3rd vaginal cuff is remove Type 3- also called as Meig Hysterectomy The cardinal ligament is divided near the sidewall (type 3) instead of close to its midportion near the ureteral dissection (type 2) UTerosacral ligaments divided at their origin near the sacrum A larger margin of vagina is removed in type 3 hysterectomy Complete dissection of the ureter Uterine artery divided at its origin A Type 4 hysterectomy is an extended radical hysterectomy where more parametrial and vaginal tissue is removed A type 5 hysterectomy involves partial exenteration. Part of the bladder and distal ureteral segments are also removed.</li><li>\u27a4 A Type 1 hysterectomy is also called an e xtra-fasical hysterectomy and is done in non malignant or pre-malignant conditions. It involves ligation of the uterine artery, uterosacral and cardinal ligaments at the proximal part No vaginal cuff is removed</li><li>\u27a4 It involves ligation of the uterine artery, uterosacral and cardinal ligaments at the proximal part No vaginal cuff is removed</li><li>\u27a4 It involves ligation of the uterine artery, uterosacral and cardinal ligaments at the proximal part</li><li>\u27a4 No vaginal cuff is removed</li><li>\u27a4 A Type 2 hysterectomy (Wertheim hysterectomy) Uterine arteries divided just medial to the ureter Uterosacral ligaments divided midway Cardinal ligaments divided midway 2/3rd vaginal cuff is remove</li><li>\u27a4 Uterine arteries divided just medial to the ureter Uterosacral ligaments divided midway Cardinal ligaments divided midway 2/3rd vaginal cuff is remove</li><li>\u27a4 Uterine arteries divided just medial to the ureter</li><li>\u27a4 Uterosacral ligaments divided midway</li><li>\u27a4 Cardinal ligaments divided midway</li><li>\u27a4 2/3rd vaginal cuff is remove</li><li>\u27a4 Type 3- also called as Meig Hysterectomy The cardinal ligament is divided near the sidewall (type 3) instead of close to its midportion near the ureteral dissection (type 2) UTerosacral ligaments divided at their origin near the sacrum A larger margin of vagina is removed in type 3 hysterectomy Complete dissection of the ureter Uterine artery divided at its origin</li><li>\u27a4 The cardinal ligament is divided near the sidewall (type 3) instead of close to its midportion near the ureteral dissection (type 2) UTerosacral ligaments divided at their origin near the sacrum A larger margin of vagina is removed in type 3 hysterectomy Complete dissection of the ureter Uterine artery divided at its origin</li><li>\u27a4 The cardinal ligament is divided near the sidewall (type 3) instead of close to its midportion near the ureteral dissection (type 2)</li><li>\u27a4 UTerosacral ligaments divided at their origin near the sacrum</li><li>\u27a4 A larger margin of vagina is removed in type 3 hysterectomy</li><li>\u27a4 Complete dissection of the ureter</li><li>\u27a4 Uterine artery divided at its origin</li><li>\u27a4 A Type 4 hysterectomy is an extended radical hysterectomy where more parametrial and vaginal tissue is removed</li><li>\u27a4 A type 5 hysterectomy involves partial exenteration. Part of the bladder and distal ureteral segments are also removed.</li><li>\u27a4 Ref : Berek and Novak, 16 th edition, page 2476</li><li>\u27a4 Ref : Berek and Novak, 16 th edition, page 2476</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a088a5ba",
      "audio": ""
    },
    {
      "text": "Mrs Anita, a 70 year old woman has been counselled about radical hysterectomy and radiotherapy as treatment modalities for her cervcal cancer treatment. Meig\u2019s Radical hysterectomy or type III hysterectomy involves removal of:",
      "options": [
        {
          "label": "A",
          "text": "Uterus+ cervix + upper 1/3 rd of vagina + pelvic lymph nodes + medial half of cardinal ligament",
          "correct": false
        },
        {
          "label": "B",
          "text": "Uterus + cervix + upper 2/3 rd of vagina + pelvic lymph nodes + most of cardinal ligament",
          "correct": true
        },
        {
          "label": "C",
          "text": "Uterus + cervix + upper 2/3 rd of vagina + pelvic lymph nodes + medial half of cardinal ligament",
          "correct": false
        },
        {
          "label": "D",
          "text": "Uterus + cervix + upper 1/3 rd of vagina + pelvic lymph nodes + most of cardinal ligament",
          "correct": false
        }
      ],
      "correct_answer": "B. Uterus + cervix + upper 2/3 rd of vagina + pelvic lymph nodes + most of cardinal ligament",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Types of hysterectomies:</li><li>\u27a4 Types of hysterectomies:</li><li>\u27a4 A Type 1 hysterectomy is also called an e xtra-fasical hysterectomy and is done in non malignant or pre-malignant conditions. It involves ligation of the uterine artery, uterosacral and cardinal ligaments at the proximal part No vaginal cuff is removed A Type 2 hysterectomy (Wertheim hysterectomy) Uterine arteries divided just medial to the ureter Uterosacral ligaments divided midway Cardinal ligaments divided midway 2/3rd vaginal cuff is remove Type 3- also called as Meig Hysterectomy The cardinal ligament is divided near the sidewall (type 3) instead of close to its midportion near the ureteral dissection (type 2) Uterosacral ligaments divided at their origin near the sacrum A larger margin of vagina is removed in type 3 hysterectomy (2/3rd) Complete dissection of the ureter Uterine artery divided at its origin A Type 4 hysterectomy is an extended radical hysterectomy where more parametrial and vaginal tissue is removed A type 5 hysterectomy involves partial exenteration. Part of the bladder and distal ureteral segments are also removed</li><li>\u27a4 A Type 1 hysterectomy is also called an e xtra-fasical hysterectomy and is done in non malignant or pre-malignant conditions. It involves ligation of the uterine artery, uterosacral and cardinal ligaments at the proximal part No vaginal cuff is removed</li><li>\u27a4 It involves ligation of the uterine artery, uterosacral and cardinal ligaments at the proximal part No vaginal cuff is removed</li><li>\u27a4 It involves ligation of the uterine artery, uterosacral and cardinal ligaments at the proximal part</li><li>\u27a4 No vaginal cuff is removed</li><li>\u27a4 A Type 2 hysterectomy (Wertheim hysterectomy) Uterine arteries divided just medial to the ureter Uterosacral ligaments divided midway Cardinal ligaments divided midway 2/3rd vaginal cuff is remove</li><li>\u27a4 Uterine arteries divided just medial to the ureter Uterosacral ligaments divided midway Cardinal ligaments divided midway 2/3rd vaginal cuff is remove</li><li>\u27a4 Uterine arteries divided just medial to the ureter</li><li>\u27a4 Uterosacral ligaments divided midway</li><li>\u27a4 Cardinal ligaments divided midway</li><li>\u27a4 2/3rd vaginal cuff is remove</li><li>\u27a4 Type 3- also called as Meig Hysterectomy The cardinal ligament is divided near the sidewall (type 3) instead of close to its midportion near the ureteral dissection (type 2) Uterosacral ligaments divided at their origin near the sacrum A larger margin of vagina is removed in type 3 hysterectomy (2/3rd) Complete dissection of the ureter Uterine artery divided at its origin</li><li>\u27a4 The cardinal ligament is divided near the sidewall (type 3) instead of close to its midportion near the ureteral dissection (type 2) Uterosacral ligaments divided at their origin near the sacrum A larger margin of vagina is removed in type 3 hysterectomy (2/3rd) Complete dissection of the ureter Uterine artery divided at its origin</li><li>\u27a4 The cardinal ligament is divided near the sidewall (type 3) instead of close to its midportion near the ureteral dissection (type 2)</li><li>\u27a4 Uterosacral ligaments divided at their origin near the sacrum</li><li>\u27a4 A larger margin of vagina is removed in type 3 hysterectomy (2/3rd)</li><li>\u27a4 Complete dissection of the ureter</li><li>\u27a4 Uterine artery divided at its origin</li><li>\u27a4 A Type 4 hysterectomy is an extended radical hysterectomy where more parametrial and vaginal tissue is removed</li><li>\u27a4 A type 5 hysterectomy involves partial exenteration. Part of the bladder and distal ureteral segments are also removed</li><li>\u27a4 Ref : berek and novak, 16 th edition, page 2476</li><li>\u27a4 Ref : berek and novak, 16 th edition, page 2476</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c2aef1e7",
      "audio": ""
    },
    {
      "text": "Mrs Rina, a 35 year old P1L1 has 1.5 x 1.5cm growth limited to the cervix. A biopsy reveals squamous cell carcinomal of the cervix and an MRI reveals no other involvement of surrounding structures. She wishes to undergo fertility preserving surgery and future childbearing . Which of the following would be an appropriate management for her:",
      "options": [
        {
          "label": "A",
          "text": "Laparoscopic hysterectomy with preservation of ovaries",
          "correct": false
        },
        {
          "label": "B",
          "text": "Laparoscopic hysterectomy with transposition of ovaries",
          "correct": false
        },
        {
          "label": "C",
          "text": "Radical trachelectomy",
          "correct": true
        },
        {
          "label": "D",
          "text": "Simple trachelectomy",
          "correct": false
        }
      ],
      "correct_answer": "C. Radical trachelectomy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Radical trachelectomy.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2de507c1",
      "audio": ""
    },
    {
      "text": "Which of the following stage of cancer cervix would best be managed surgically?",
      "options": [
        {
          "label": "A",
          "text": "Stage IB3",
          "correct": false
        },
        {
          "label": "B",
          "text": "Stage IIA1",
          "correct": true
        },
        {
          "label": "C",
          "text": "Stage IIA2",
          "correct": false
        },
        {
          "label": "D",
          "text": "Stage IIB",
          "correct": false
        }
      ],
      "correct_answer": "B. Stage IIA1",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Stage IIA1</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Staging and Treatment of cervical cancer is shown in the table below</li><li>\u27a4 Staging and Treatment of cervical cancer is shown in the table below</li><li>\u27a4 Stage</li><li>\u27a4 Stage</li><li>\u27a4 Disease</li><li>\u27a4 Disease</li><li>\u27a4 Treatment</li><li>\u27a4 Treatment</li><li>\u27a4 1A1</li><li>\u27a4 < 3mm (- LVSI)</li><li>\u27a4 Conization or extra-fascial hysterectomy</li><li>\u27a4 < 3mm (+ LVSI)</li><li>\u27a4 Modified radical trachelectomy or modified radical hysterectomy + pelvic lymphadenectomy</li><li>\u27a4 1A2</li><li>\u27a4 \u2265 3mm < 5mm</li><li>\u27a4 Modified radical trachelectomy or modified radical hysterectomy + pelvic lymphadenectomy</li><li>\u27a4 1B1</li><li>\u27a4 \u2265 5mm < 2mm</li><li>\u27a4 Modified radical/ radical trachelectomy or modified radical/ radical hysterectomy with pelvic lymphadenectomy</li><li>\u27a4 1B2</li><li>\u27a4 \u2265 2cm < 4cm</li><li>\u27a4 Radical hysterectomy with pelvic lymphadenectomy</li><li>\u27a4 1B3</li><li>\u27a4 >4cm</li><li>\u27a4 Chemoradiation (pelvic field)</li><li>\u27a4 2A1</li><li>\u27a4 < 4 cm + involvement of upper vagina</li><li>\u27a4 Radical hysterectomy with pelvic lymphadenectomy OR Chemoradiation</li><li>\u27a4 2A2</li><li>\u27a4 \u2265 4cm + involvement of upper vagina</li><li>\u27a4 Chemoradiation (pelvic field)</li><li>\u27a4 2B</li><li>\u27a4 Cervix + involvement of parametria (not till vaginal wall)</li><li>\u27a4 Chemoradiation (pelvic field)</li><li>\u27a4 3A</li><li>\u27a4 Cervix + lower vagina</li><li>\u27a4 Chemoradiation (pelvic field)</li><li>\u27a4 3B</li><li>\u27a4 Cervix + pelvic wall OR hydronephrosis</li><li>\u27a4 Chemoradiation (pelvic \u00b1 extended field)</li><li>\u27a4 3C1</li><li>\u27a4 Cervix + pelvic lymph nodes</li><li>\u27a4 Chemoradiation (pelvic \u00b1 extended field)</li><li>\u27a4 3C2</li><li>\u27a4 Cervix + para-aortic lymph nodes</li><li>\u27a4 Chemoradiation (pelvic \u00b1 extended field)</li><li>\u27a4 4A</li><li>\u27a4 Cervix + Adjacent pelvic organs</li><li>\u27a4 Chemoradiation (pelvic \u00b1 extended field) OR exenteration</li><li>\u27a4 4B</li><li>\u27a4 Cervix + Distant mets</li><li>\u27a4 Systemic chemotherapy \u00b1 radiation</li><li>\u27a4 Ref: Berek and Novak\u2019s 16 th edition, page 2471, 2472</li><li>\u27a4 Ref: Berek and Novak\u2019s 16 th edition, page 2471, 2472</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "705c05a9",
      "audio": ""
    },
    {
      "text": "A 35-year-old woman presents to her gynecologist for her routine checkup. She reports no significant medical history and has been in good health. Her last pap smear was 5 years earlier and was normal. Her pelvic examination reveals a slightly enlarged cervix with a raised, friable lesion which bleeds on touch. A biopsy is performed, and histopathology confirms the presence of squamous cell carcinoma. Which of the following risk factors is most strongly associated with the development of cervical squamous cell carcinoma?",
      "options": [
        {
          "label": "A",
          "text": "Early age at first sexual intercourse",
          "correct": true
        },
        {
          "label": "B",
          "text": "Nulliparity",
          "correct": false
        },
        {
          "label": "C",
          "text": "Hormone replacement therapy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Family h/o breast cancer",
          "correct": false
        }
      ],
      "correct_answer": "A. Early age at first sexual intercourse",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. Early age at first sexual intercourse</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Risk Factors for cervical cancer</li><li>\u2022 Risk Factors for cervical cancer</li><li>\u2022 HPV (most important and also cause of cervical cancer) Early age at 1 st intercourse Sexually transmitted diseases Early age at marriage Multiple births Low socio-economic status HIV +ve Multiple sexual partners Smoking Uncertain relation with Combined OCPs</li><li>\u2022 HPV (most important and also cause of cervical cancer)</li><li>\u2022 Early age at 1 st intercourse</li><li>\u2022 Sexually transmitted diseases</li><li>\u2022 Early age at marriage</li><li>\u2022 Multiple births</li><li>\u2022 Low socio-economic status</li><li>\u2022 HIV +ve</li><li>\u2022 Multiple sexual partners</li><li>\u2022 Smoking</li><li>\u2022 Uncertain relation with Combined OCPs</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Infection with HPV is the most important risk factor and also cause of cervical cancer</li><li>\u27a4 Infection with HPV is the most important risk factor and also cause of cervical cancer</li><li>\u27a4 Ref: Page 338, DC Dutta\u2019s Textbook of Gynecology 6 th edition</li><li>\u27a4 Ref: Page 338, DC Dutta\u2019s Textbook of Gynecology 6 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "02677853",
      "audio": ""
    },
    {
      "text": "Which human papillomavirus (HPV) subtype is most commonly associated with adenocarcinoma of the cervix?",
      "options": [
        {
          "label": "A",
          "text": "HPV 6",
          "correct": false
        },
        {
          "label": "B",
          "text": "HPV 16",
          "correct": false
        },
        {
          "label": "C",
          "text": "HPV 18",
          "correct": true
        },
        {
          "label": "D",
          "text": "HPV 31",
          "correct": false
        }
      ],
      "correct_answer": "C. HPV 18",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 HPV is the primary etiologic infectious agent associated with cervical cancer High-risk HPV types include types 16, 18, 31, 33, 34, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68, and 70 Majority of cervical cancers are attributed to HPV 16 and 18 HPV 16 is more commonly associated with squamous cell carcinoma of the cervix HPV 18 is a risk actor or cervical adenocarcinoma</li><li>\u2022 HPV is the primary etiologic infectious agent associated with cervical cancer</li><li>\u2022 High-risk HPV types include types 16, 18, 31, 33, 34, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68, and 70</li><li>\u2022 Majority of cervical cancers are attributed to HPV 16 and 18</li><li>\u2022 HPV 16 is more commonly associated with squamous cell carcinoma of the cervix</li><li>\u2022 HPV 18 is a risk actor or cervical adenocarcinoma</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Majority of cervical cancers are attributed to high risk HPV types 16 and 18</li><li>\u27a4 Majority of cervical cancers are attributed to high risk HPV types 16 and 18</li><li>\u27a4 Ref: Page 684, Williams Gynecology 3 rd edition</li><li>\u27a4 Ref: Page 684, Williams Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7da48519",
      "audio": ""
    },
    {
      "text": "A 54y woman presents to the OPD with post-menopausal bleeding. On a speculum examination, there is a fungating 4x3 cm growth seen arising from the cervix. A biopsy is taken but the patient starts profusely bleeding. Which of the following is not used for hemostasis in cases of life-threatening hemorrhage from suspected cervical cancer?",
      "options": [
        {
          "label": "A",
          "text": "Lugol solution",
          "correct": true
        },
        {
          "label": "B",
          "text": "Emergent radiation",
          "correct": false
        },
        {
          "label": "C",
          "text": "Uterine artery embolization",
          "correct": false
        },
        {
          "label": "D",
          "text": "Monsel (ferric subsulfate) solution",
          "correct": false
        }
      ],
      "correct_answer": "A. Lugol solution",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Cervical cancer typically bleeds on touch and sometimes can present with heavy bleeding or during an examination, torrential bleeding can start from the tumor bed In such cases, bleeding can often be controlled with Vaginal packing Combination of Monsel paste (ferric subsulfate) Topical acetone can also be used to obtain hemostasis, especially in cases refractory to Monsel paste If bleeding continues, emergent radiation can be delivered. Uterine artery or Internal iliac artery embolization or ligation can be performed in cases of refractory hemorrhage Lugol\u2019s iodine is not going to stop the bleeding. It is used as a test for cervical cancer screening</li><li>\u2022 Cervical cancer typically bleeds on touch and sometimes can present with heavy bleeding or during an examination, torrential bleeding can start from the tumor bed</li><li>\u2022 In such cases, bleeding can often be controlled with Vaginal packing Combination of Monsel paste (ferric subsulfate) Topical acetone can also be used to obtain hemostasis, especially in cases refractory to Monsel paste If bleeding continues, emergent radiation can be delivered. Uterine artery or Internal iliac artery embolization or ligation can be performed in cases of refractory hemorrhage</li><li>\u2022 Vaginal packing Combination of Monsel paste (ferric subsulfate) Topical acetone can also be used to obtain hemostasis, especially in cases refractory to Monsel paste If bleeding continues, emergent radiation can be delivered. Uterine artery or Internal iliac artery embolization or ligation can be performed in cases of refractory hemorrhage</li><li>\u2022 Vaginal packing</li><li>\u2022 Combination of Monsel paste (ferric subsulfate)</li><li>\u2022 Topical acetone can also be used to obtain hemostasis, especially in cases refractory to Monsel paste</li><li>\u2022 If bleeding continues, emergent radiation can be delivered.</li><li>\u2022 Uterine artery or Internal iliac artery embolization or ligation can be performed in cases of refractory hemorrhage</li><li>\u2022 Lugol\u2019s iodine is not going to stop the bleeding. It is used as a test for cervical cancer screening</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cervical cancer typically bleeds on touch and sometimes can present with heavy bleeding or during an examination, torrential bleeding can start from the tumor bed In such cases, bleeding can often be controlled with Vaginal packing Combination of Monsel paste (ferric subsulfate) Topical acetone can also be used to obtain hemostasis, especially in cases refractory to Monsel paste If bleeding continues, emergent radiation can be delivered. Uterine artery or Internal iliac artery embolization or ligation can be performed in cases of refractory hemorrhage</li><li>\u27a4 Cervical cancer typically bleeds on touch and sometimes can present with heavy bleeding or during an examination, torrential bleeding can start from the tumor bed</li><li>\u27a4 In such cases, bleeding can often be controlled with Vaginal packing Combination of Monsel paste (ferric subsulfate) Topical acetone can also be used to obtain hemostasis, especially in cases refractory to Monsel paste If bleeding continues, emergent radiation can be delivered. Uterine artery or Internal iliac artery embolization or ligation can be performed in cases of refractory hemorrhage</li><li>\u27a4 Vaginal packing Combination of Monsel paste (ferric subsulfate) Topical acetone can also be used to obtain hemostasis, especially in cases refractory to Monsel paste If bleeding continues, emergent radiation can be delivered. Uterine artery or Internal iliac artery embolization or ligation can be performed in cases of refractory hemorrhage</li><li>\u27a4 Vaginal packing</li><li>\u27a4 Combination of Monsel paste (ferric subsulfate)</li><li>\u27a4 Topical acetone can also be used to obtain hemostasis, especially in cases refractory to Monsel paste</li><li>\u27a4 If bleeding continues, emergent radiation can be delivered.</li><li>\u27a4 Uterine artery or Internal iliac artery embolization or ligation can be performed in cases of refractory hemorrhage</li><li>\u27a4 Ref: Page 662, Williams Gynecology 3 rd edition</li><li>\u27a4 Ref: Page 662, Williams Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3fd7dde7",
      "audio": ""
    },
    {
      "text": "A woman comes in for an annual gynecologic examination. During speculum examination, you see the following. What is the most appropriate next step?",
      "options": [
        {
          "label": "A",
          "text": "Perform a pap smear",
          "correct": false
        },
        {
          "label": "B",
          "text": "Perform a cervical biopsy",
          "correct": true
        },
        {
          "label": "C",
          "text": "Refer to a gynecologic oncologist",
          "correct": false
        },
        {
          "label": "D",
          "text": "Obtain a computed tomography (CT) scan",
          "correct": false
        }
      ],
      "correct_answer": "B. Perform a cervical biopsy",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/18/picture118_GSGLEOW.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 When a lesion is seen on the cervix, a biopsy should always be taken using a punch biopsy forceps In this image, a lesion is seen, so a biopsy should be taken from the periphery of the lesion</li><li>\u2022 When a lesion is seen on the cervix, a biopsy should always be taken using a punch biopsy forceps</li><li>\u2022 In this image, a lesion is seen, so a biopsy should be taken from the periphery of the lesion</li><li>\u2022 Other options</li><li>\u2022 Other options</li><li>\u2022 A pap smear is done when there is no visible lesion on the cervix Imaging studies and referral to a gyn oncologist have a role in cervical cancer once a diagnosis is made</li><li>\u2022 A pap smear is done when there is no visible lesion on the cervix</li><li>\u2022 Imaging studies and referral to a gyn oncologist have a role in cervical cancer once a diagnosis is made</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 When a lesion is seen on the cervix, a biopsy should always be taken using a punch biopsy forceps In this image, a lesion is seen, so a biopsy should be taken from the periphery of the lesion</li><li>\u27a4 When a lesion is seen on the cervix, a biopsy should always be taken using a punch biopsy forceps</li><li>\u27a4 In this image, a lesion is seen, so a biopsy should be taken from the periphery of the lesion</li><li>\u27a4 Ref: Page no 663, Williams Gynecology 3 rd edition</li><li>\u27a4 Ref: Page no 663, Williams Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7b460d24",
      "audio": ""
    },
    {
      "text": "A woman has a 6-cm adenocarcinoma of the cervix, positive para-aortic nodes found on positron emission tomography (PET) scan, and hydronephrosis. Based on these findings, which FIGO stage is she assigned?",
      "options": [
        {
          "label": "A",
          "text": "IB2",
          "correct": false
        },
        {
          "label": "B",
          "text": "IIB",
          "correct": false
        },
        {
          "label": "C",
          "text": "IIIB",
          "correct": true
        },
        {
          "label": "D",
          "text": "IVB",
          "correct": false
        }
      ],
      "correct_answer": "C. IIIB",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/18/picture23_ZC18iSO.jpg"
      ],
      "explanation": "<p><strong>Ans. C. IIIB</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 This is stage 3B due to the finding of hydronephrosis</li><li>\u2022 This is stage 3B due to the finding of hydronephrosis</li><li>\u2022 FIGO Staging of cervical cancer (2021)</li><li>\u2022 FIGO Staging of cervical cancer (2021)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cervical cancer staging is a clinical staging which is aided by imaging and pathology.</li><li>\u27a4 Cervical cancer staging is a clinical staging which is aided by imaging and pathology.</li><li>\u27a4 Ref: Berek and Novak 16 th edition, 2455</li><li>\u27a4 Ref: Berek and Novak 16 th edition, 2455</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fd107fe8",
      "audio": ""
    },
    {
      "text": "Which of the following arrows depicts where the uterosacral ligament is ligated during a type II radical hysterectomy?",
      "options": [
        {
          "label": "A",
          "text": "A",
          "correct": false
        },
        {
          "label": "B",
          "text": "B",
          "correct": true
        },
        {
          "label": "C",
          "text": "C",
          "correct": false
        },
        {
          "label": "D",
          "text": "Anywhere",
          "correct": false
        }
      ],
      "correct_answer": "B. B",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/18/whatsapp-image-2023-12-18-at-174605.jpeg"
      ],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/18/screenshot-2023-12-18-180615.jpg"
      ],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Types of Hysterectomy</li><li>\u2022 Types of Hysterectomy</li><li>\u2022 In this image, they have shown the utero-sacral ligaments and have asked about a type 2 hysterectomy; hence midway is the best answer</li><li>\u2022 In this image, they have shown the utero-sacral ligaments and have asked about a type 2 hysterectomy; hence midway is the best answer</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In a type 2 radical hysterectomy, the uterine vessels are ligated at the level of the ureter and the uterosacral ligaments are divided midway between the uterus and the sacrum In a type 3 hysterectomy, the uterine vessels are ligated at the origin of the internal iliac vessels and the uterosacral ligaments are ligated near the sacrum</li><li>\u27a4 In a type 2 radical hysterectomy, the uterine vessels are ligated at the level of the ureter and the uterosacral ligaments are divided midway between the uterus and the sacrum</li><li>\u27a4 In a type 3 hysterectomy, the uterine vessels are ligated at the origin of the internal iliac vessels and the uterosacral ligaments are ligated near the sacrum</li><li>\u27a4 Ref: Page 171, Williams Gynecology, 3 rd edition</li><li>\u27a4 Ref: Page 171, Williams Gynecology, 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cf56df7d",
      "audio": ""
    },
    {
      "text": "In brachytherapy for cervical cancer, how is point A defined?",
      "options": [
        {
          "label": "A",
          "text": "2 cm lateral and 2 cm superior to the external os",
          "correct": true
        },
        {
          "label": "B",
          "text": "5 cm lateral and 2 cm superior to the external os",
          "correct": false
        },
        {
          "label": "C",
          "text": "2 cm lateral and 5 cm superior to the external os",
          "correct": false
        },
        {
          "label": "D",
          "text": "5 cm lateral and 2 cm superior to the internal os",
          "correct": false
        }
      ],
      "correct_answer": "A. 2 cm lateral and 2 cm superior to the external os",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/18/whatsapp-image-2023-12-18-at-180614.jpeg"
      ],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Radiotherapy in cervical cancer</li><li>\u2022 Radiotherapy in cervical cancer</li><li>\u2022 Both external beam pelvic radiation and brachytherapy are typically delivered Of these, external beam radiation is usually given before intracavitary radiation (brachytherapy) External beam radiation is commonly administered in 25 fractions during 5 weeks (40 to 50 Gy). During brachytherapy, bowel and bladder are packed away from the intracavitary source using vaginal packing during tandem insertion to limit radiation to these organs. Treatment is prescribed to Point A : A point 2 cm lateral and 2 cm superior to the external cervical os; this point corresponds to the crossing of the uterine artery and ureter Point B: which is a point 3 cm lateral to point A; this point corresponds to the lateral pelvic wall/ obturator lymph nodes</li><li>\u2022 Both external beam pelvic radiation and brachytherapy are typically delivered</li><li>\u2022 Of these, external beam radiation is usually given before intracavitary radiation (brachytherapy)</li><li>\u2022 External beam radiation is commonly administered in 25 fractions during 5 weeks (40 to 50 Gy).</li><li>\u2022 During brachytherapy, bowel and bladder are packed away from the intracavitary source using vaginal packing during tandem insertion to limit radiation to these organs.</li><li>\u2022 Treatment is prescribed to Point A : A point 2 cm lateral and 2 cm superior to the external cervical os; this point corresponds to the crossing of the uterine artery and ureter Point B: which is a point 3 cm lateral to point A; this point corresponds to the lateral pelvic wall/ obturator lymph nodes</li><li>\u2022 Point A : A point 2 cm lateral and 2 cm superior to the external cervical os; this point corresponds to the crossing of the uterine artery and ureter Point B: which is a point 3 cm lateral to point A; this point corresponds to the lateral pelvic wall/ obturator lymph nodes</li><li>\u2022 Point A : A point 2 cm lateral and 2 cm superior to the external cervical os; this point corresponds to the crossing of the uterine artery and ureter</li><li>\u2022 Point A</li><li>\u2022 Point B: which is a point 3 cm lateral to point A; this point corresponds to the lateral pelvic wall/ obturator lymph nodes</li><li>\u2022 Point B:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 In cervical cancer, radiotherapy (brachytherapy) is prescribed to 2 points Treatment is prescribed to Point A: A point 2 cm lateral and 2 cm superior to the external cervical os; this point corresponds to the crossing of the uterine artery and ureter Point B: which is a point 3 cm lateral to point A; this point corresponds to the lateral pelvic wall/ obturator lymph nodes</li><li>\u27a4 In cervical cancer, radiotherapy (brachytherapy) is prescribed to 2 points</li><li>\u27a4 In cervical cancer, radiotherapy (brachytherapy) is prescribed to 2 points</li><li>\u27a4 Treatment is prescribed to Point A: A point 2 cm lateral and 2 cm superior to the external cervical os; this point corresponds to the crossing of the uterine artery and ureter Point B: which is a point 3 cm lateral to point A; this point corresponds to the lateral pelvic wall/ obturator lymph nodes</li><li>\u27a4 Point A: A point 2 cm lateral and 2 cm superior to the external cervical os; this point corresponds to the crossing of the uterine artery and ureter Point B: which is a point 3 cm lateral to point A; this point corresponds to the lateral pelvic wall/ obturator lymph nodes</li><li>\u27a4 Point A: A point 2 cm lateral and 2 cm superior to the external cervical os; this point corresponds to the crossing of the uterine artery and ureter</li><li>\u27a4 Point A:</li><li>\u27a4 Point B: which is a point 3 cm lateral to point A; this point corresponds to the lateral pelvic wall/ obturator lymph nodes</li><li>\u27a4 Point B:</li><li>\u27a4 Ref: page 672, Williams Gynecology 3 rd edition</li><li>\u27a4 Ref: page 672, Williams Gynecology 3 rd edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "681dde2b",
      "audio": ""
    },
    {
      "text": "If a patient with stage IB1 squamous cell carcinoma recurs at the vagina after a radical hysterectomy with pelvic lymph node dissection, what is the most appropriate treatment?",
      "options": [
        {
          "label": "A",
          "text": "Radiation alone",
          "correct": false
        },
        {
          "label": "B",
          "text": "Chemotherapy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Total pelvic exenteration",
          "correct": false
        },
        {
          "label": "D",
          "text": "Radiation with concomitant chemotherapy",
          "correct": true
        }
      ],
      "correct_answer": "D. Radiation with concomitant chemotherapy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 The given scenario is of a recurrence R isk factors for recurrent disease are: Large tumor size Lymph vascular space invasion Positive lymph nodes Advanced stage disease Most common site of recurrence is the pelvic side wall. Features of disease recurrence are: Pain in the pelvis, back, unilateral leg edema, ureteral obstruction, vaginal bleeding, palpable tumor in the pelvis and lymphadenopathy. Treatment of recurrence: Single agent or multiagent chemotherapy with cisplatin, paclitaxel or ifosfamide is used along with Radiation therapy may be used to those who have been treated initially with surgery.</li><li>\u2022 The given scenario is of a recurrence</li><li>\u2022 The given scenario is of a recurrence</li><li>\u2022 R isk factors for recurrent disease are: Large tumor size Lymph vascular space invasion Positive lymph nodes Advanced stage disease</li><li>\u2022 R</li><li>\u2022 Large tumor size Lymph vascular space invasion Positive lymph nodes Advanced stage disease</li><li>\u2022 Large tumor size</li><li>\u2022 Lymph vascular space invasion</li><li>\u2022 Positive lymph nodes</li><li>\u2022 Advanced stage disease</li><li>\u2022 Most common site of recurrence is the pelvic side wall.</li><li>\u2022 Features of disease recurrence are: Pain in the pelvis, back, unilateral leg edema, ureteral obstruction, vaginal bleeding, palpable tumor in the pelvis and lymphadenopathy.</li><li>\u2022 Treatment of recurrence: Single agent or multiagent chemotherapy with cisplatin, paclitaxel or ifosfamide is used along with Radiation therapy may be used to those who have been treated initially with surgery.</li><li>\u2022 Single agent or multiagent chemotherapy with cisplatin, paclitaxel or ifosfamide is used along with Radiation therapy may be used to those who have been treated initially with surgery.</li><li>\u2022 Single agent or multiagent chemotherapy with cisplatin, paclitaxel or ifosfamide is used along with Radiation therapy may be used to those who have been treated initially with surgery.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Treatment of recurrence of cervical cancer: Single agent or multiagent chemotherapy with cisplatin, paclitaxel or ifosfamide is used along with Radiation therapy may be used to those who have been treated initially with surgery.</li><li>\u27a4 Treatment of recurrence of cervical cancer: Single agent or multiagent chemotherapy with cisplatin, paclitaxel or ifosfamide is used along with Radiation therapy may be used to those who have been treated initially with surgery.</li><li>\u27a4 Single agent or multiagent chemotherapy with cisplatin, paclitaxel or ifosfamide is used along with Radiation therapy may be used to those who have been treated initially with surgery.</li><li>\u27a4 Single agent or multiagent chemotherapy with cisplatin, paclitaxel or ifosfamide is used along with Radiation therapy may be used to those who have been treated initially with surgery.</li><li>\u27a4 Ref: Page 354, DC Duttas Textbook of Gynecology 6 th edition</li><li>\u27a4 Ref: Page 354, DC Duttas Textbook of Gynecology 6 th edition</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "16b656ea",
      "audio": ""
    }
  ]
}